Home
  >  
Section 42

EurekaMag Full Text Articles Chapter 41,492



References:

Kobayashi, S.; Naitoh, T.; Nakadate, T.; Kimura, I.; Kimura, M. 1992: Suppression by high glucose concentration of insulin receptor up-regulation in diaphragm and flexor digitorum brevis muscles from diabetic KK-CAy and streptozotocin-diabetic mice. Journal of Pharmacobio-Dynamics 15(4): 175-180
Salmon, D.M.; Hems, D.A. 1976: Suppression by insulin of net triacylglycerol depletion in the perfused mouse liver. Biochemical Society Transactions 4(4): 659-662
Gomis, R.; Novials, A.; Coves, M.J.; Casamitjana, R.; Malaisse, W.J. 1989: Suppression by insulin treatment of glucose-induced inhibition of insulin release in non-insulin-dependent diabetics. Diabetes Research and Clinical Practice 6(3): 191-198
Labussière, J.; Lacroix, M.C.; Combaud, J.F.; de la Chevalerie, F.A.; Thomas, P. 1990: Suppression by luteectomy of the simultaneous increase in intramammary pressure and blood oxytocin levels induced by the injection of PGF2-alpha in ewes. Reproduction Nutrition Development 30(1): 91-96
Zhalgasbaeva, G.T. 1976: Suppression by means of the BCG vaccine of specific antitumor immunity to tumors caused by the virus SV40 in Syrian hamsters. Vestnik Akademii Meditsinskikh Nauk SSSR 2: 15-21
Wainfan, E.; Dizik, M. 1987: Suppression by methionine and choline of onco-fetal patterns of liver tRNA methyltransferase activities in carcinogen-treated rats. Carcinogenesis 8(4): 615-617
Okamura, T.; Yoshida, K.; Toda, N. 1990: Suppression by methylene blue of prostaglandin I2 synthesis in isolated dog renal arteries. Journal of Pharmacology and Experimental Therapeutics 254(1): 198-203
Watson, R.R.; Nguyen, T.H. 1990: Suppression by morphine and ethanol of tumor cell cytotoxic activity released by macrophages from retrovirally infected mice upon in vitro stimulation by beta carotene. Progress in Clinical and Biological Research 325: 79-91
Ishii, K.; Kato, R. 1987: Suppression by muscarinic M2 stimulation of the contractile mechanism via histamine H1 receptors in the longitudinal muscle of guinea pig ileum. Journal of Pharmacology and Experimental Therapeutics 241(2): 587-593
Grundemar, L.; Grundström, N.; Johansson, I.G.; Andersson, R.G.; Håkanson, R. 1990: Suppression by neuropeptide y of capsaicin-sensitive sensory nerve-mediated contraction in guinea-pig airways. British Journal of Pharmacology 99(3): 473-476
Imai, H.; Ikuta, K.; Ueda, S.; Suehiro, S.; Yamamoto, N.; Kato, S. 1987: Suppression by neurotropin of production of human immuno-deficiency virus by the virus-producing MOLT-4 cell line. Japanese Journal of Cancer Research: Gann 78(7): 648-650
Donaldson, I.M.; Long, A.C.; Tasker, T.C. 1978: Suppression by nitrous oxide of visual responses in the cerebellar vermis and superior colliculus of cats anaesthetized with chloralose. Brain Research 148(2): 526-529
Takemori, A.E.; Schwartz, M.M.; Portoghese, P.S. 1988: Suppression by nor-binaltorphimine of kappa opioid-mediated diuresis in rats. Journal of Pharmacology and Experimental Therapeutics 247(3): 971-974
Mountford, P.J.; Heap, R.B.; Hamon, M.; Fleet, I.R.; Coakley, A.J. 1987: Suppression by perchlorate of technetium-99m and iodine-123 secretion in milk of lactating goats. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 28(7): 1187-1191
Keller, R. 1979: Suppression by radioactive strontium of the spontaneous cytotoxicity expressed by adherent, predominantly phagocytic cells from various mouse tissues. Immunology 37(2): 333-338
Duwe, A.K.; Singhal, S.K. 1976: Suppression by soluble factor released from B cells. Advances in Experimental Medicine and Biology 66: 607-615
Ebihara, T.; Sakai, N.; Koyama, S. 1991: Suppression by sorted CD8+CD11b- cells from T-cell growth factor-activated peripheral blood lymphocytes on cytolytic activity against tumour in patients with gastric carcinoma. European Journal of Cancer 27(12): 1654-1657
Saeki, S.; Yaksh, T.L. 1992: Suppression by spinal alpha-2 agonists of motor and autonomic responses evoked by low- and high-intensity thermal stimuli. Journal of Pharmacology and Experimental Therapeutics 260(2): 795-802
Yamashita, Y.; Hasegawa-Sasaki, H.; Sasaki, T. 1991: Suppression by staurosporine of Ca(2+)-mobilization triggered by ligation of antigen-specific receptors on t and B lymphocytes. An essential role of protein tyrosine kinase in the signal transduction. Febs Letters 288(1-2): 46-50
Teh, B.S.; Ioannoni, B.; Seow, W.K.; McCormack, J.G.; Thong, Y.H. 1989: Suppression by tetrandrine of human platelet aggregation induced by platelet-activating factor and other stimulants. International Archives of Allergy and Applied Immunology 88(3): 267-272
Deeney, C.M.; Goodson, M.; Rossouw, F.T.; Rowbury, R.J. 1986: Suppression by the ColV,I-K94 plasmid of a growth lesion in ompA mutants of Escherichia coli. Journal of General Microbiology 132(8): 2287-2295
Reakes, C.F.; Deeney, C.M.; Goodson, M.; Rowbury, R.J. 1988: Suppression by the ColV,I-K94 plasmid of inhibitor sensitivities in ompA mutants of Escherichia coli. Canadian Journal of Microbiology 34(2): 148-156
Kistler, A. 1986: Suppression by the cyclohexanetrione Ro 31-0521 of retinoic acid-induced teratogenicity. Experientia 42(1): 50-52
Wolf, R.E.; Goldstein, A.L.; Ziff, M. 1978: Suppression by thymosin of pokeweed mitogen-induced differentiation of human B cells. Clinical Immunology and Immunopathology 11(3): 303-306
Maeda, K.; Kato, Y.; Chihara, K.; Ogo, S.; Iwasaki, Y. 1975: Suppression by thyrotropin-releasing hormone (TRH) of human growth hormone release induced by L-dopa. Journal of Clinical Endocrinology and Metabolism 41(2): 408-411
Palmer, A.R.; Harrison, R.V. 1985: Suppression by tones of the click evoked compound action potential in the normal and pathological guinea-pig cochlea and in man. Scandinavian Audiology 14(2): 67-74
Gundersen, C.B.; Umbach, J.A. 1992: Suppression cloning of the cDNA for a candidate subunit of a presynaptic calcium channel. Neuron 9(3): 527-537
Mazo, A.M.; Mizrokhi, L.J.; Karavanov, A.A.; Sedkov, Y.A.; Krichevskaja, A.A.; Ilyin, Y.V. 1989: Suppression in Drosophila: su(Hw) and su(f) gene products interact with a region of gypsy (mdg4) regulating its transcriptional activity. EMBO Journal 8(3): 903-911
Pritchard-Briscoe, H.; Loblay, R.H. 1989: Suppression in an adoptive hapten-carrier system. Research in Immunology 140(3): 313-7; Discussion 339-45
Streilein, J.W.; Mohler, K.M. 1989: Suppression in class Ii MHC tolerance is mediated by Ia-specific lymphocytes that fail to mature into allodestructive effectors. Transplantation Proceedings 21(1 Part 1): 236-237
Nabozny, G.H.; Simon, L.L.; Kong, Y.C. 1990: Suppression in experimental autoimmune thyroiditis: the role of unique and shared determinants on mouse thyroglobulin in self-tolerance. Cellular Immunology 131(1): 140-149
Nabozny, G.H.; Cobbold, S.P.; Waldmann, H.; Kong, Y.C. 1991: Suppression in murine experimental autoimmune thyroiditis: in vivo inhibition of CD4+ T cell-mediated resistance by a nondepleting rat CD4 monoclonal antibody. Cellular Immunology 138(1): 185-196
Shimada, M.; Murayama, N.; Yamauchi, K.; Yamazoe, Y.; Kato, R. 1989: Suppression in the expression of a male-specific cytochrome P450, P450-male: difference in the effect of chemical inducers on P450-male mRNA and protein in rat livers. Archives of Biochemistry and Biophysics 270(2): 578-587
Bosch, F.X.; Schwarz, E.; Boukamp, P.; Fusenig, N.E.; Bartsch, D.; zur Hausen, H. 1990: Suppression in vivo of human papillomavirus type 18 E6-E7 gene expression in nontumorigenic Hela X fibroblast hybrid cells. Journal of Virology 64(10): 4743-4754
Nojiri, C.; Okano, T.; Park, K.D.; Kim, S.W. 1988: Suppression mechanisms for thrombus formation on heparin-immobilized segmented polyurethane-ureas. Asaio Transactions 34(3): 386-398
Miki, J.; Fujiwara, K.; Tsuda, M.; Tsuchiya, T.; Kanazawa, H. 1990: Suppression mutations in the defective beta subunit of F1-ATPase from Escherichia coli. Journal of Biological Chemistry 265(35): 21567-21572
Eichmann, K. 1988: Suppression needs a new hypothesis. Scandinavian Journal of Immunology 28(3): 273-276
De Boland, A.R.; Boland, R. 1985: Suppression of 1,25-dihydroxy-vitamin D3-dependent calcium transport by protein synthesis inhibitors and changes in phospholipids in skeletal muscle. Biochimica et Biophysica Acta 845(2): 237-241
Saitoh, T. 1988: Suppression of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity in mouse brain by piroheptine and trihexyphenidyl. Journal of the Neurological Sciences 83(2-3): 161-166
Izumi, T.; Shishikura, K.; Fukuyama, Y. 1986: Suppression of 2', 3'-cyclic nucleotide 3'-phosphohydrolase activity in suckling rat brain by ACTH. Brain and Development 8(5): 500-504
Lahav, M.; Lamprecht, S.A.; Amsterdam, A.; Lindner, H.R. 1977: Suppression of 20 alpha-hydroxysteroid dehydrogenase activity in cultured rat luteal cells by prolactin. Molecular and Cellular Endocrinology 6(4-5): 293-302
Karlsson, R.; Lindén, A.; von Schoultz, B. 1992: Suppression of 24-hour cholecystokinin secretion by oral contraceptives. American Journal of Obstetrics and Gynecology 167(1): 58-59
Catapano, A.L.; Gianturco, S.H.; Kinnunen, P.K.; Eisenberg, S.; Gotto, A.M.; Smith, L.C. 1979: Suppression of 3-hydroxy-3-methylglutaryl-CoA reductase by low density lipoproteins produced in vitro by lipoprotein lipase action on nonsuppressive very low density lipoproteins. Journal of Biological Chemistry 254(4): 1007-1009
St Clair, W.H. 1991: Suppression of 3-methylcholanthrene-induced cellular transformation by timed administration of the Bowman-Birk protease inhibitor. Carcinogenesis 12(5): 935-937
Nakada, T.; Katayama, T.; Shimazaki, J. 1979: Suppression of 3H-lysine incorporation into the vascular non-collagenous protein in rats treated with estradiol-17 beta. European Journal of Pharmacology 59(1-2): 31-36
Nagayama, Y.; Fukase, M. 1978: Suppression of 3H-thymidine incorporation into PHA-stimulated lymphocytes by testosterone. Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 41(1): 11-16
Chesnut, T.J.; Swann, J.W. 1990: Suppression of 4-aminopyridine-induced epileptogenesis by the GABAA agonist muscimol. Epilepsy Research 5(1): 8-17
Gean, P.W.; Chou, S.M. 1991: Suppression of 4-aminopyridine-induced paroxysmal depolarizing shift in rat amygdaloid neurons by diltiazem. Brain Research 560(1-2): 306-310
Jellinck, P.H.; Galbraith, R.A. 1991: Suppression of 5 alpha-androstane-3 beta,17 beta-diol hydroxylase activity in rat pituitary by cobalt protoporphyrin: implications for testosterone homeostasis. Journal of Steroid Biochemistry and Molecular Biology 39(6): 947-951
Imanishi, H.; Sasaki, Y.F.; Matsumoto, K.; Watanabe, M.; Ohta, T.; Shirasu, Y.; Tutikawa, K. 1990: Suppression of 6-TG-resistant mutations in V79 cells and recessive spot formations in mice by vanillin. Mutation Research 243(2): 151-158
Feuer, G.; Kellen, J.A.; Kovacs, K. 1976: Suppression of 7,12-dimethylbenz(alpha) anthracene-induced breast carcinoma by coumarin in the rat. Oncology 33(1): 35-39
Epstein, M.; Pins, D.S.; Miller, M. 1975: Suppression of ADH during water immersion in normal man. Journal of Applied Physiology 38(6): 1038-1044
Tikasingh, E.S.; Eustace, A. 1992: Suppression of Aedes aegypti by predatory Toxorhynchites moctezuma in an island habitat. Medical and Veterinary Entomology 6(3): 272-280
Atkins, E.; Francis, L. 1985: Suppression of Ag-induced release of EP (IL 1) by spleen cells of specifically desensitized donors: evidence for the role of a suppressor cell. Journal of Immunology 134(4): 2436-2443
Cohen, S.; Yoshida, T. 1977: Suppression of B cell MIF production by T cells and soluble T cell-derived factors. Journal of Immunology 119(2): 719-721
Wicker, L.S.; Boltz, R.C.; Matt, V.; Nichols, E.A.; Peterson, L.B.; Sigal, N.H. 1990: Suppression of B cell activation by cyclosporin A, FK506 and rapamycin. European Journal of Immunology 20(10): 2277-2283
Cerny, A.; Hügin, A.W.; Sutter, S.; Heusser, C.H.; Bos, N.; Izui, S.; Hengartner, H.; Zinkernagel, R.M. 1985: Suppression of B cell development and antibody responses in mice with polyclonal rabbit and monoclonal rat anti-IgM antibodies. I. Characterization of the suppressed state. Experimental Cell Biology 53(6): 301-313
Tucker, A.N.; Vore, S.J.; Luster, M.I. 1986: Suppression of B cell differentiation by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Molecular Pharmacology 29(4): 372-377
Beining, P.R.; Merchant, B.; Lizzio, E.F.; Hoffman, T. 1986: Suppression of B cell immunity to DNP by serotherapy with monoclonal anti-DNP antibodies. Effect of the treatment schedule on the magnitude of specific suppression and its duration. Transplantation 42(5): 524-528
Katz, P.; Mitchell, S.R.; Cupps, T.R.; Evans, M.; Whalen, G. 1989: Suppression of B cell responses by natural killer cells is mediated through direct effects on T cells. Cellular Immunology 119(1): 130-142
Xenocostas, A.; Lapp, W.S.; Osmond, D.G. 1987: Suppression of B lymphocyte genesis in the bone marrow by systemic graft-versus-host reactions. Transplantation 43(4): 549-555
Rogers, T.J.; DeHaven, J.I.; Donnelly, R.P. 1985: Suppression of B-cell and T-cell responses by the prostaglandin-induced T-cell-derived suppressors (PITS)--III. Production of PITS beta factors from T-cell hybridomas. International Journal of Immunopharmacology 7(1): 153-156
Siegal, F.P.; Siegal, M.; Good, R.A. 1976: Suppression of B-cell differentiation by leukocytes from hypogammaglobulinemic patients. Journal of Clinical Investigation 58(1): 109-122
Suzuki, S.; Suzuki, R.; Onta, T.; Kumagai, K. 1986: Suppression of B-cell differentiation by natural killer (asialo GM1+) cells in mice. Natural Immunity and Cell Growth Regulation 5(2): 75-89
Venkataraman, M.; Rao, D.S.; Levin, R.D.; Westerman, M.P. 1985: Suppression of B-lymphocyte function by T-lymphocytes in patients with advanced lung cancer. Journal of the National Cancer Institute 74(1): 37-41
Portolani, M.; Pietrosemoli, P.; Cermelli, C.; Mannini-Palenzona, A.; Grossi, M.P.; Paolini, L.; Barbanti-Brodano, G. 1988: Suppression of BK virus replication and cytopathic effect by inhibitors of prokaryotic DNA gyrase. Antiviral Research 9(3): 205-218
Scheinberg, M.A.; Israel Filho, G.; Mendes, N.F.; Vertzman, L. 1978: Suppression of C3 rosette formation by serum from patients with systemic lupus erythematosus. a corollary of disease activity. Journal of Rheumatology 5(1): 19-25
Sultzer, B.M.; Bandekar, J.R.; Castagna, R.; Abu-Lawi, K.; Sadeghian, M.; Norin, A.J. 1992: Suppression of C3H/HeJ cell activation by lipopolysaccharide endotoxin. Infection and Immunity 60(9): 3533-3538
Yokoyama, M.; Naganuma, A.; Imura, N. 1985: Suppression of CDDP-induced renal toxicity by sodium selenite. Gan no Rinsho. Japan Journal of Cancer Clinics 31(9 Suppl): 1225-1230
Kobashi, H.; Miyoshi, I.; Tsubota, T.; Hiraki, S.; Kubonishi, I.; Kimura, I.; Sezaki, T.; Asano, K. 1979: Suppression of CFU-C by bone marrow lymphocytes from hypoplastic anemia. Japanese Journal of Clinical Hematology 20(12): 1562-1568
Van den Engh, G.; Platenburg, M. 1978: Suppression of CFU-s activity by rabbit-anti-mouse brain serum can be overcome by treatment with papain. Experimental Hematology 6(7): 627-630
Kortz, E.O.; Sachs, D.H. 1989: Suppression of CML reactivity by non-T cells from miniature swine tolerant of a class i mismatched renal allograft. Current Surgery 46(2): 107-110
Dooley, T.P.; Polisky, B. 1987: Suppression of ColE1 RNA-RNA mismatch mutations in vivo by the ColE1 Rop protein. Plasmid 18(1): 24-34
Nomaguchi, H.; Dohi, Y.; Ohno, N.; Fujiwara, T.; Ito, T. 1989: Suppression of Con a response of mouse lymphocytes with unique M. leprae glycolipid. Nihon Rai Gakkai Zasshi 58(3): 191-196
De Gast, G.C.; The, T.H.; Ponds, E.; Kallenberg, C. 1977: Suppression of DNA synthesis by Con A-activated human lymphocytes: Stimulation by con A bound to non-T cells unless removed after activation. Clinical and Experimental Immunology 30(3): 457-464
DiSorbo, D.M.; Harris, N.A.; Nathanson, L. 1985: Suppression of DNA synthesis in NEL-M1 human melanoma cells by triamcinolone acetonide. Cancer Research 45(4): 1633-1637
Volgareva, E.V.; Protasova, S.F. 1987: Suppression of DNA synthesis in lymphocytes by UV-irradiated plasma. Biulleten' Eksperimental'noi Biologii i Meditsiny 104(8): 205-206
Reznikova, M.I.; Dudnik, I.V. 1988: Suppression of DNA synthesis in mice by the anthracycline antibiotics daunorubicin, carminomycin and doxorubicin. Antibiotiki i Khimioterapiia 33(4): 286-289
Gutowski, J.K.; Cohen, S. 1987: Suppression of DNA synthesis in normal, but not neoplastic, nuclei by cytoplasmic extracts from resting cells. Cellular Immunology 106(1): 174-179
Chirkov, G.P.; Sizova, S.T.; Efremova, O.I.; Gutnikova, M.N.; Kudriashova, E.A. 1976: Suppression of DNA-ligase deficiency and selective breeding of mutants and recombinants of T4 phage with phenotype rIi. Genetika 12(6): 95-102
Nanba, H. 1977: Suppression of DNCB contact hypersensitivity by anti-hapten-antibody. Nihon Hifuka Gakkai Zasshi. Japanese Journal of Dermatology 87(7): 411-417
Herrmann, P.; Schreier, M.H.; Borel, J.F. 1986: Suppression of DTH mediated by cloned helper T cells with ciclosporin and dexamethasone. Agents and Actions 19(5-6): 280-281
Gupta, C.; Hattori, A.; Shinozuka, H. 1988: Suppression of EGF binding in rat liver by the hypolipidemic peroxisome proliferators, 4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio-(N-beta-hydroxyethyl)ac etamide and di(2-ethylhexyl)phthalate. Carcinogenesis 9(1): 167-169
Fung, K.P.; Chan, T.W.; Choy, Y.M. 1985: Suppression of Ehrlich ascites tumor growth in mice by starvation and streptozotocin-induced diabetes. Cancer Letters 28(3): 273-280
Wleklik, M.; Levy, S.B.; Luczak, M.; Najjar, V.A. 1986: Suppression of Friend virus-induced leukaemia in mice by tuftsin. Journal of General Virology 67: 2001-2004
De Boer, T.; Metselaar, H.J.; Bruinvels, J. 1977: Suppression of GABA-induced abstinence behaviour in naive rats by morphine and bicuculline. Life Sciences 20(6): 933-941
Kanai, Y.; Aosaki, T.; Wada, O.; Manabe, S. 1989: Suppression of GABA-induced chloride current by 3-amino-1-methyl-5H-pyrido[4,3-b]indole (Trp-P-2). European Journal of Pharmacology 166(3): 553-556
Siegl, E.; Brock, J.; Schulze, H.A. 1987: Suppression of GvHR by in vitro allogeneically stimulated lymphocytes: the role of lymphoblasts in the regulation of a primary T-cell response. Cellular Immunology 104(2): 218-222
Polsky, D.; Lilly, F. 1991: Suppression of H-2b-associated resistance to Friend erythroleukemia virus by a class i gene from the H-2d major histocompatibility complex haplotype. Proceedings of the National Academy of Sciences of the United States of America 88(20): 9243-9247
Yamashita, Y.; Koike, K.; Takaoki, M.; Matsuda, S. 1988: Suppression of HBsAg production in PLC/PRF/5 human hepatoma cell line by interferons. Microbiology and Immunology 32(11): 1119-1126
Shinitzky, M.; Skornick, Y. 1990: Suppression of HIV antigenaemia by AL721. Lancet 335(8700): 1281-1282
McCune, J.M.; Namikawa, R.; Shih, C.C.; Rabin, L.; Kaneshima, H. 1990: Suppression of HIV infection in AZT-treated SCID-hu mice. Science 247(4942): 564-566
Brook, M.G.; Gor, D.; Forster, S.M.; Harris, W.; Jeffries, D.J.; Thomas, H.C. 1988: Suppression of HIV p24 antigen and induction of HIV anti-p24 antibody by alpha interferon in patients with chronic hepatitis B. Aids 2(5): 391-393
Vasudevachari, M.B.; Mast, T.C.; Salzman, N.P. 1990: Suppression of HIV-1 reverse transcriptase activity by mycoplasma contamination of cell cultures. Aids Research and Human Retroviruses 6(3): 411-416
Guerin, V.; Todd, I.; Hammond, L.J.; Bottazzo, G.F. 1990: Suppression of HLA class Ii expression on thyrocytes by interferon-alpha 1. Clinical and Experimental Immunology 79(3): 341-345
Grant, D.; Grasso, P. 1978: Suppression of Hela cell growth and increase in nuclear size by chemical carcinogens: a possible screening method. Mutation Research 57(3): 369-380
Vogler, A.P.; Broekhuizen, C.P.; Schuitema, A.; Lengeler, J.W.; Postma, P.W. 1988: Suppression of IIIGlc-defects by enzymes IINag and IIBgl of the PEP:carbohydrate phosphotransferase system. Molecular Microbiology 2(6): 719-726
Numerof, R.P.; Sipe, J.D.; Trehu, E.G.; Dinarello, C.A.; Mier, J.W. 1992: Suppression of IL-2-induced SAA gene expression in mice by the administration of an IL-1 receptor antagonist. Cytokine 4(6): 555-560
Wei, B.Y.; Carter, B.G.; Holford-Strevens, V.; Sehon, A.H. 1986: Suppression of IgE and non-IgE antibodies to industrial chemicals by conjugates of polyvinyl alcohol. Journal of Allergy and Clinical Immunology 78(5 Part 2): 1066-1070
Ngan, J.; Kind, L.S. 1979: Suppression of IgE antibody formation in mice: requirement for T-T lymphocyte interaction. International Archives of Allergy and Applied Immunology 58(2): 195-201
Ozawa, M.; Fujimaki, H.; Imai, T.; Honda, Y.; Watanabe, N. 1985: Suppression of IgE antibody production after exposure to ozone in mice. International Archives of Allergy and Applied Immunology 76(1): 16-19
Watanabe, N.; Kojima, S.; Ovary, Z. 1976: Suppression of IgE antibody production in SJL mice. I. Nonspecific suppressor T cells. Journal of Experimental Medicine 143(4): 833-845
Watanabe, N.; Kojima, S.; Shen, F.W.; Ovary, Z. 1977: Suppression of IgE antibody production in SJL mice. II. Expression of Ly-1 antigen on helper and nonspecific suppressor T cells. Journal of Immunology 118(2): 485-488
Watanabe, N.; Ovary, Z. 1977: Suppression of IgE antibody production in SJL mice. III. Characterization of a suppressor substance extracted from normal SJL spleen cells. Journal of Experimental Medicine 145(6): 1501-1510
Itaya, T.; Ovary, Z. 1979: Suppression of IgE antibody production in SJL mice. IV. Interaction of primed and unprimed T cells. Journal of Experimental Medicine 150(3): 507-516
Okada, M.; Matsushima, A.; Katsuhata, A.; Aoyama, T.; Ando, T.; Inada, Y. 1985: Suppression of IgE antibody response against ovalbumin by the chemical conjugate of ovalbumin with a polyaspartic acid derivative. International Archives of Allergy and Applied Immunology 76(1): 79-81
Holt, P.G.; Reid, M.; Britten, D.; Sedgwick, J.; Bazin, H. 1987: Suppression of IgE responses by passive antigen inhalation: dissociation of local (mucosal) and systemic immunity. Cellular Immunology 104(2): 434-439
Maekawa, S.; de Szalay, C.; Ovary, Z. 1985: Suppression of IgE secretion from hybridoma cells in allotype congenic mice: suppression of allotype 7a by T cells in allotype b mice. Proceedings of the National Academy of Sciences of the United States of America 82(23): 8134-8138
Zaunders, J.J.; Cooper, D.A.; Young, Y.; Duckett, M.; Penny, R.; Ziegler, J.B. 1985: Suppression of IgE synthesis in vitro by allogeneic T cells from atopic and non-atopic subjects. Clinical and Experimental Immunology 62(1): 193-199
Bezvershenko, I.; Gjulling, E.; Dyugovskaya, L. 1979: Suppression of IgE-antibody production by non-polypeptide dialysable thymic factor. Immunology 36(2): 229-234
Van Buskirk, A.M.; Braley-Mullen, H. 1987: Suppression of IgG memory responses by T cells activated with the type 2 antigen polyvinylpyrrolidone (PVP). Cellular Immunology 107(1): 121-129
Nishi, N.; Coy, D.H.; Coy, E.J.; Arimura, A.; Schally, A.V. 1976: Suppression of LH-RH-induced ovulation in hamsters and rats by synthetic analogues of LH-RH. Journal of Reproduction and Fertility 48(1): 119-124
Fedorovskaia, E.O.; Pelevina, I.I.; Afanas'ev, G.G.; Ershov, F.I.; Grigorian, S.S. 1989: Suppression of Lewis carcinoma metastasis in mice by an interferon-inducing vasodilator curantil. Biulleten' Eksperimental'noi Biologii i Meditsiny 107(1): 83-85
Caceres, A.; Mautino, J.; Kosik, K.S. 1992: Suppression of MAP2 in cultured cerebellar macroneurons inhibits minor neurite formation. Neuron 9(4): 607-618
Lenardo, M.; Rustgi, A.K.; Schievella, A.R.; Bernards, R. 1989: Suppression of MHC class I gene expression by N-myc through enhancer inactivation. EMBO Journal 8(11): 3351-3355
Krzystyniak, K.; Bernier, J.; Hugo, P.; Fournier, M. 1986: Suppression of MHV3 virus-activated macrophages by dieldrin. Biochemical Pharmacology 35(15): 2577-2586
Taura, Y.; Stein, E.; Mullen, Y. 1990: Suppression of MLR and DTH responses in miniature swine by pretreatment with ultraviolet (UV)-irradiated peripheral blood lymphocytes. Nihon Juigaku Zasshi. Japanese Journal of Veterinary Science 52(6): 1163-1170
Sakato, N.; Hall, S.H.; Eisen, H.N. 1979: Suppression of MOPC-167 growth in vivo by immunization against the idiotype of the MOPC-167 myeloma protein. Microbiology and Immunology 23(9): 927-931
Melamed, E.; Rosenthal, J.; Globus, M.; Cohen, O.; Uzzan, A. 1985: Suppression of MPTP-induced dopaminergic neurotoxicity in mice by nomifensine and L-DOPA. Brain Research 342(2): 401-404
Imanishi, J.; Watanabe, H.; Horii, Y.; Sugimoto, T. 1987: Suppression of N-myc over-expression in human neuroblastic cells by human gamma-interferon. Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 181(4): 454-457
Broaddus, R.R.; Mayberry, L.F.; Bristol, J.R.; Upton, S.J. 1987: Suppression of Nippostrongylus brasiliensis (Nematoda)-induced lysophospholipase activity and peripheral eosinophilia by Eimeria nieschulzi (Apicomplexa). Journal of Parasitology 73(4): 739-742
Howard, I.P.; Giaschi, D.; Murasugi, C.M. 1989: Suppression of OKN and VOR by afterimages and imaginary objects. Experimental Brain Research 75(1): 139-145
Hartung, H.P.; Schäfer, B.; Diamantstein, T.; Fierz, W.; Heininger, K.; Toyka, K.V. 1989: Suppression of P2-T cell line-mediated experimental autoimmune neuritis by interleukin-2 receptor targeted monoclonal antibody ART 18. Brain Research 489(1): 120-128
Hartung, H.P.; Schäfer, B.; Diamantstein, T.; Fierz, W.; Heininger, K.; Toyka, K.V. 1988: Suppression of P2-T-cell line mediated experimental autoimmune neuritis by interleukin-2 receptor blockade. Annals of the new York Academy of Sciences 540: 563-565
Morgan, E.T. 1991: Suppression of P450IIC12 gene expression and elevation of actin messenger ribonucleic acid levels in the livers of female rats after injection of the interferon inducer poly rI.poly rC. Biochemical Pharmacology 42(1): 51-57
Nijkamp, F.P.; Folkerts, G.; Beetens, J.R.; De Clerck, F. 1989: Suppression of PAF-induced bronchoconstriction in the guinea-pig by oxatomide: mechanism of action. Naunyn-Schmiedeberg's Archives of Pharmacology 340(1): 111-118
Byron, K.; Young, G.A.; Khazan, N.; Hong, O. 1985: Suppression of PCP-induced behavioral arousal in the rat by yohimbine pretreatment. European Journal of Pharmacology 117(2): 271-273
Kishimoto, R.A.; Gonder, J.C. 1979: Suppression of PHA-stimulated lymphocyte transformation in cynomolgus monkeys following infection with Coxiella burnetii. Canadian Journal of Microbiology 25(8): 949-952
Finch, J.L.; Brown, A.J.; Mori, T.; Nishii, Y.; Slatopolsky, E. 1992: Suppression of PTH and decreased action on bone are partially responsible for the low calcemic activity of 22-oxacalcitriol relative to 1,25-(OH)2D3. Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research 7(7): 835-839
Page, C.P.; Tomiak, R.H.; Sanjar, S.; Morley, J. 1985: Suppression of Paf-acether responses: an anti-inflammatory effect of anti-asthma drugs. Agents and Actions 16(1-2): 33-35
Condreay, L.D.; Brown, D.T. 1988: Suppression of RNA synthesis by a specific antiviral activity in Sindbis virus-infected Aedes albopictus cells. Journal of Virology 62(1): 346-348
Gelman, I.H.; Hanafusa, H. 1989: Suppression of Rous sarcoma virus-induced tumor formation by preinfection with viruses encoding src protein with novel N termini. Journal of Virology 63(6): 2461-2468
Pararajasegaram, G.; Sevanian, A.; Rao, N.A. 1991: Suppression of S antigen-induced uveitis by vitamin E supplementation. Ophthalmic Research 23(3): 121-127
Djian, P.; Phillips, M.; Green, H. 1988: Suppression of SV40-promoted gene expression by differentiation of preadipose cells. Genes and Development 2(10): 1251-1257
Ishihara, C.; Mizukoshi, N.; Iida, J.; Kato, K.; Yamamoto, K.; Azuma, I. 1987: Suppression of Sendai virus growth by treatment with N alpha-acetylmuramyl-L-alanyl-D-isoglutaminyl-N epsilon-stearoyl-L-lysine in mice. Vaccine 5(4): 295-301
Pryjma, J.; Pituch-Noworolska, A.; Flad, H.D.; Ulmer, A.J.; Ernst, M. 1986: Suppression of Staphylococcus aureus Cowan I-induced immunoglobulin synthesis in vitro: discrimination between the presence of suppressor T cell precursors and effectors. Clinical and Experimental Immunology 66(2): 348-357
Udou, T.; Ichikawa, Y. 1978: Suppression of Staphylococcus aureus extracellular nuclease and alpha-toxin synthesis by acetylmethylcarbinol. Infection and Immunity 20(3): 873-874
Caufield, P.W.; Gibbons, R.J. 1979: Suppression of Streptococcus mutans in the mouths of humans by a dental prophylaxis and topically-applied iodine. Journal of Dental Research 58(4): 1317-1326
Ikeda, T.; Kurita, T.; Hirasawa, M. 1988: Suppression of Streptococcus sobrinus 6715 (g) in plaques by Streptococcus mutans 32K (c). Journal of Oral Pathology 17(9-10): 471-474
Sasiain, M.C.; de la Barrera, S.; Ruibal Ares, B.; Picchio, G.; Muchinik, G.; Pérez Bianco, R.; de Tezanos Pinto, M.; de Bracco, M.M. 1990: Suppression of T cell proliferation induced by concanavalin a in hemophilia patients. Medicina 50(3): 205-212
Ting, C.C.; Rodrigues, D.; Ting, R.C.; Wivel, N.; Collins, M.J. 1979: Suppression of T cell-mediated immunity by tumor cells: immunogenicity versus immunosuppression and preliminary characterization of the suppressive factors. International Journal of Cancer 24(5): 644-655
Sanders, G.E.; Perrillo, R.P. 1985: Suppression of T helper function: an immunoregulatory effect of rosette inhibitory factor in hepatitis B virus infection. Hepatology 5(3): 392-396
Brown, S.L.; Van Epps, D.E. 1985: Suppression of T lymphocyte chemotactic factor production by the opioid peptides beta-endorphin and met-enkephalin. Journal of Immunology 134(5): 3384-3390
Pross, S.; Newton, C.; Klein, T.; Widen, R.; Smith, J.; Friedman, H. 1991: Suppression of T lymphocyte subpopulations by THC. Advances in Experimental Medicine and Biology 288: 113-117
Molloy, A.; Gaudernack, G.; Levis, W.R.; Cohn, Z.A.; Kaplan, G. 1990: Suppression of T-cell proliferation by Mycobacterium leprae and its products: the role of lipopolysaccharide. Proceedings of the National Academy of Sciences of the United States of America 87(3): 973-977
Chemtai, A.K.; Okelo, G.B. 1989: Suppression of T-cell proliferative response in Plasmodium falciparum malaria patients--preliminary results. East African Medical Journal 66(12): 787-791
Uchida, A.; Klein, E. 1986: Suppression of T-cell response in autologous mixed lymphocyte-tumor culture by large granular lymphocytes. Journal of the National Cancer Institute 76(3): 389-398
Nehlsen, S.L.; Lalezari, P. 1977: Suppression of T-cell-mediated immune responses by sodium cyanate. Transplantation Proceedings 9(1): 997-1000
House, R.V.; Lauer, L.D.; Murray, M.J.; Dean, J.H. 1987: Suppression of T-helper cell function in mice following exposure to the carcinogen 7,12-dimethylbenz[a]anthracene and its restoration by interleukin-2. International Journal of Immunopharmacology 9(1): 89-97
Niwano, Y.; Hansen, T.R.; Kazemi, M.; Malathy, P.V.; Johnson, H.D.; Roberts, R.M.; Imakawa, K. 1989: Suppression of T-lymphocyte blastogenesis by ovine trophoblast protein-1 and human interferon-alpha may be independent of interleukin-2 production. American Journal of Reproductive Immunology 20(1): 21-26
Lyle, D.B.; Ayotte, R.D.; Sheppard, A.R.; Adey, W.R. 1988: Suppression of T-lymphocyte cytotoxicity following exposure to 60-Hz sinusoidal electric fields. Bioelectromagnetics 9(3): 303-313
Rieder, M.J.; Sisson, E.; Bird, I.A.; Almawi, W.Y. 1992: Suppression of T-lymphocyte proliferation by sulphonamide hydroxylamines. International Journal of Immunopharmacology 14(7): 1175-1180
Cox, R.A.; Kennell, W. 1988: Suppression of T-lymphocyte response by Coccidioides immitis antigen. Infection and Immunity 56(6): 1424-1429
Salata, R.A.; Martinez-Palomo, A.; Canales, L.; Murray, H.W.; Trevino, N.; Ravdin, J.I. 1990: Suppression of T-lymphocyte responses to Entamoeba histolytica antigen by immune sera. Infection and Immunity 58(12): 3941-3946
Gupta, S.; Grieco, M.H.; Siegel, I. 1975: Suppression of T-lymphocyte rosettes by rifampin. Studies in normals and patients with tuberculosis. Annals of Internal Medicine 82(4): 484-488
Boucher, A.; Matte, R.; Bélanger, R.; Boutin, J.M.; Havrankova, J.; Ste-Marie, L.G.; Carrier, L.; D'Amour, P. 1989: Suppression of T4 secretion in a metastatic follicular carcinoma. Clinical and Investigative Medicine. Medecine Clinique et Experimentale 12(3): 162-164
Kamijo, R.; Takeda, K.; Nagumo, M.; Konno, K. 1989: Suppression of TNF-stimulated proliferation of diploid fibroblasts and TNF-induced cytotoxicity against transformed fibroblasts by TGF-beta. Biochemical and Biophysical Research Communications 158(1): 155-162
Cosio, F.G.; Goicolea, A.; López Gil, M.; Kallmeyer, C.; Barroso, J.L. 1991: Suppression of Torsades de Pointes with verapamil in patients with atrio-ventricular block. European Heart Journal 12(5): 635-638
Suzuki, N.; Suzuki, H. 1988: Suppression of UV mutagenicity by human interferon. Mutation Research 202(1): 179-183
Mäepea, O.; Nilsson, S.F. 1991: Suppression of VIP- and terbutaline stimulated aqueous humor flow by increased intraocular pressure in the cynomolgus monkey. Current Eye Research 10(8): 703-712
Brayley, K.N.; Albert, D.J. 1977: Suppression of VMH-lesion-induced reactivity and aggressiveness in the rat by stimulation of lateral septum, but not medial septum or cingulate cortex. Journal of Comparative and Physiological Psychology 91(2): 290-299
Radner, B.S.; Kennedy, A.R. 1986: Suppression of X-ray induced transformation by vitamin e in mouse C3H/10T1/2 cells. Cancer Letters 32(1): 25-32
Theall, G.; Low, K.B.; Söll, D. 1977: Suppression of a defective alanyl-tRNA synthetase in Escherichia coli: a compensatory mutation to high alanine affinity. Molecular and General Genetics: Mgg 156(2): 221-227
Tanemura, S.; Bauerle, R. 1979: Suppression of a deletion mutation in the glutamine amidotransferase region of the Salmonella typhimurium trpD gene by mutations in pheA and tyrA. Journal of Bacteriology 139(2): 573-582
Pages, D.; Hijazi, K.; Murgola, E.J.; Finelli, J.; Buckingham, R.H. 1991: Suppression of a double missense mutation by a mutant tRNA(Phe) in Escherichia coli. Nucleic Acids Research 19(4): 867-869
Chu, C.C.; Templin, A.; Clark, A.J. 1989: Suppression of a frameshift mutation in the recE gene of Escherichia coli K-12 occurs by gene fusion. Journal of Bacteriology 171(4): 2101-2109
Brissette, R.E.; Tsung, K.L.; Inouye, M. 1991: Suppression of a mutation in OmpR at the putative phosphorylation center by a mutant EnvZ protein in Escherichia coli. Journal of Bacteriology 173(2): 601-608
Burke, J.F.; Mogg, A.E. 1985: Suppression of a nonsense mutation in mammalian cells in vivo by the aminoglycoside antibiotics G-418 and paromomycin. Nucleic Acids Research 13(17): 6265-6272
Pisko, E.J.; Foster, S.L.; White, R.E.; Panetti, M.; Turner, R.A. 1986: Suppression of a pokeweed mitogen-stimulated plaque-forming cell response by a human B lymphocyte-derived aggregated IgG-stimulated suppressor factor: suppressive B cell factor (SBF). Journal of Immunology 136(6): 2141-2150
Wolos, J.A.; Spagnoli, B.; Smith, J.B. 1985: Suppression of a polyclonal B-cell response by supernatants from the murine autologous mixed lymphocyte reaction. Cellular Immunology 96(1): 61-70
Kumagaye, K.Y.; Inui, T.; Nakajima, K.; Kimura, T.; Sakakibara, S. 1991: Suppression of a side reaction associated with N(im)-benzyloxymethyl group during synthesis of peptides containing cysteinyl residue at the N-terminus. Peptide Research 4(2): 84-87
Cover, W.H.; Ryan, J.P.; Bassford, P.J.; Walsh, K.A.; Bollinger, J.; Randall, L.L. 1987: Suppression of a signal sequence mutation by an amino acid substitution in the mature portion of the maltose-binding protein. Journal of Bacteriology 169(5): 1794-1800
Laqbaqbi, A.; Lehn, E.; Tardivel, P. 1988: Suppression of a subcardial diverticulum of the stomach. Presse Medicale 17(11): 533-535
Chesney, R.H.; Scott, J.R. 1978: Suppression of a thermosensitive dnaA mutation of Escherichia coli by bacteriophage P1 and P7. Plasmid 1(2): 145-163
Haisch, C.E.; Lodge, P.A.; Lamoureux, C.; Thomas, F.T. 1992: Suppression of a xenogeneic mixed lymphocyte endothelial cell culture with 15-deoxyspergualin. Transplantation Proceedings 24(2): 439-440
Inoue, K.; Kera, Y.; Kiriyama, T.; Komura, S. 1985: Suppression of acetaldehyde accumulation by 4-methylpyrazole in alcohol-hypersensitive Japanese. Japanese Journal of Pharmacology 38(1): 43-48
Galinsky, R.E.; Corcoran, G.B. 1988: Suppression of acetaminophen conjugation and of conjugate elimination in the rat by metyrapone, a classical P-450 inhibitor. Drug Metabolism and Disposition: the Biological Fate of Chemicals 16(3): 348-354
Simmons, R.D.; Hugh, A.R.; Willenborg, D.O.; Cowden, W.B. 1992: Suppression of active but not passive autoimmune encephalomyelitis by dual cyclo-oxygenase and 5-lipoxygenase inhibition. Acta Neurologica Scandinavica 85(3): 197-199
Fan, S.F.; Dewey, M.M.; Colflesh, D.; Gaylinn, B.; Greguski, R.; Chu, B. 1985: Suppression of active cross-bridge motions of isolated thick myofilaments in suspension by phenylmethylsulfonyl fluoride. Biochimica et Biophysica Acta 827(1): 101-105
Raine, C.S.; Snyder, D.H.; Stone, S.H.; Bornstein, M.B. 1977: Suppression of acute and chronic experimental allergic encephalomyelitis in Strain 13 guinea pigs. a clinical and pathological study. Journal of the Neurological Sciences 31(3): 355-367
Brozna, J.P.; Ward, P.A. 1979: Suppression of acute and chronic inflammation in tumor-bearing rats. Journal of Clinical Investigation 64(1): 302-311
Tate, G.A.; Mandell, B.F.; Schumacher, H.R.; Zurier, R.B. 1988: Suppression of acute inflammation by 15 methyl prostaglandin E1. Laboratory Investigation; a Journal of Technical Methods and Pathology 59(2): 192-199
Cheng, J.; Yee, J.K.; Yeargin, J.; Friedmann, T.; Haas, M. 1992: Suppression of acute lymphoblastic leukemia by the human wild-type p53 gene. Cancer Research 52(1): 222-226
Su, Z.Z.; Grunberger, D.; Fisher, P.B. 1991: Suppression of adenovirus type 5 E1A-mediated transformation and expression of the transformed phenotype by caffeic acid phenethyl ester (CAPE). Molecular Carcinogenesis 4(3): 231-242
Baumgartner, R.; Obenaus, H.; Stoerk, H.C. 1975: Suppression of adjuvant arthritis (AA) by isonicotinic acid-hydracide (INH) in vitamin B6-deficient rats. Naunyn-Schmiedeberg's Archives of Pharmacology 287(Suppl): R64
Sutherland, R.I.; Quagliata, F. 1975: Suppression of adjuvant disease by bacillus Calmette-Guérin (BCG). Experientia 31(3): 367-369
Hadjipetrou-Kourounakis, L.; Rekka, E.; Kourounakis, A. 1992: Suppression of adjuvant-induced disease (AID) by a novel analgesic-opioid agonist which also possesses antioxidant activity (neuroimmunomodulation). Annals of the new York Academy of Sciences 650: 19-24
Anonymous 1987: Suppression of adrenal androgens. Lancet 2(8573): 1441-1442
Baba, K.; Mulrow, P.J.; Franco-Saenz, R.; Rapp, J.P. 1986: Suppression of adrenal renin in Dahl salt-sensitive rats. Hypertension 8(12): 1149-1153
Lahiri, P.; Sircar, S. 1991: Suppression of adrenocortical function in female mice by lindane (gamma-HCH). Toxicology 66(1): 75-79
Gu, Y.; Lin, Y.C. 1991: Suppression of adrenocorticotropic hormone (ACTH)-induced corticosterone secretion in cultured rat adrenocortical cells by gossypol and gossypolone. Research Communications in Chemical Pathology and Pharmacology 72(1): 27-38
Moriya, N.; Nagaoki, T.; Okuda, N.; Taniguchi, N. 1979: Suppression of adult B cell differentiation in pokeweed mitogen-stimulated cultures by Fc(IgG) receptor-negative T cells from cord blood. Journal of Immunology 123(4): 1795-1798
Koch, P.C.; Peters, R.H. 1987: Suppression of adult copulatory behaviors following LiCl-induced aversive contingencies in juvenile male rats. Developmental Psychobiology 20(6): 603-611
Wang, C.J.; Hsu, J.D.; Lin, J.K. 1991: Suppression of aflatoxin B1-induced hepatotoxic lesions by crocetin (a natural carotenoid). Carcinogenesis 12(10): 1807-1810
Sachan, D.S.; Yatim, A.M. 1992: Suppression of aflatoxin B1-induced lipid abnormalities and macromolecule-adduct formation by L-carnitine. Journal of Environmental Pathology Toxicology and Oncology: Official Organ of the International Society for Environmental Toxicology and Cancer 11(4): 205-210
Hufs, P.; Snepvangers, J. 1975: Suppression of aggression inside and outside of psychiatric centers. Tijdschrift Voor Ziekenverpleging 28(18): 853-856
Pucilowski, O.; Rezvani, A.H.; Janowsky, D.S. 1992: Suppression of alcohol and saccharin preference in rats by a novel Ca2+ channel inhibitor, Goe 5438. Psychopharmacology 107(2-3): 447-452
Davydova, T.V.; Barashova, L.A.; Kovalev, I.E.; Evseev, V.A. 1987: Suppression of alcohol consumption by the induction of the synthesis of serotonin antibodies. Farmakologiia i Toksikologiia 50(2): 57-58
Müller, J. 1978: Suppression of aldosterone biosynthesis by treatment of rats with adrenocorticotropin: comparison with glucocorticoid effects. Endocrinology 103(6): 2061-2068
Sherman, R.A.; Ruddy, M.C. 1986: Suppression of aldosterone production by low-dose heparin. American Journal of Nephrology 6(3): 165-168
Schwartz, K.E.; Saito, T. 1989: Suppression of alimentary lipemia in man by a prostaglandin analogue (enprostil). Atherosclerosis 79(2-3): 231-236
Bonmassar, E.; Cudkowicz, G. 1976: Suppression of allogeneic lymphomas in spleens of irradiated mice: importance of the D end of the H-2 complex. Journal of Immunology 117(2): 697-700
Kerkvliet, N.I.; Baecher-Steppan, L. 1988: Suppression of allograft immunity by 3,4,5,3',4',5'-hexachlorobiphenyl. I. Effects of exposure on tumor rejection and cytotoxic T cell activity in vivo. Immunopharmacology 16(1): 1-12
Cranston, D.; Wood, K.J.; Carter, N.P.; Morris, P.J. 1987: Suppression of allograft rejection in the rat by pretreatment with cells of the T-helper, but not T-cytotoxic suppressor phenotype. Transplantation Proceedings 19(1 Part 1): 505
Suzuki, R.; Suzuki, S.; Ebina, N.; Kumagai, K. 1985: Suppression of alloimmune cytotoxic T lymphocyte (CTL) generation by depletion of NK cells and restoration by interferon and/or interleukin 2. Journal of Immunology 134(4): 2139-2148
Holán, V.; Hasek, M.; Chutná, J. 1978: Suppression of allosensitization in vitro by cells from tolerant rats. Folia Biologica 24(2): 95-103
Tsutsumi, N.; Kanayama, K.; Tano, S. 1992: Suppression of alpha-amylase gene expression by antisense oligodeoxynucleotide in barley cultured aleurone layers. Idengaku Zasshi 67(2): 147-154
Jakab, G.J.; Risby, T.H.; Sehnert, S.S.; Hmieleski, R.R.; Farrington, J.E. 1990: Suppression of alveolar macrophage membrane receptor-mediated phagocytosis by model and actual particle-adsorbate complexes. Initial contact with the alveolar macrophage membrane. Environmental Health Perspectives 86: 337-344
Jakab, G.J.; Risby, T.H.; Sehnert, S.S.; Hmieleski, R.R.; Gilmour, M.I. 1990: Suppression of alveolar macrophage membrane-receptor-mediated phagocytosis by model particle-adsorbate complexes: physicochemical moderators of uptake. Environmental Health Perspectives 89: 169-174
Chiel, H.J.; Wurtman, R.J. 1976: Suppression of amphetamine-induced hypothermia by the neutral amino acid valine. Psychopharmacology Communications 2(3): 207-217
Morita, K.; Okamoto, M.; Seki, K.; Wada, J.A. 1985: Suppression of amygdala-kindled seizure in cats by enhanced GABAergic transmission in the substantia innominata. Experimental Neurology 89(1): 225-236
Mori, N.; Shimoyamada, K.; Kumashiro, H. 1990: Suppression of amygdaloid kindled convulsion following bilateral injection of 2-amino-7-phosphonoheptanoic acid into the substantia nigra of rats. Japanese Journal of Psychiatry and Neurology 44(2): 462-463
Mori, N.; Wada, J.A. 1989: Suppression of amygdaloid kindled convulsion following unilateral injection of 2-amino-7-phosphonoheptanoic acid (2-APH) into the substantia innominata of rats. Brain Research 486(1): 141-146
Ogawa, T.; Moriwake, T.; Morita, K.; Morimoto, K.; Okamoto, M.; Sato, M. 1985: Suppression of amygdaloid kindled seizure and regional brain GABA content. Folia Psychiatrica et Neurologica Japonica 39(3): 301-304
Bird, R.E.; Chandler, M.; Caro, L. 1976: Suppression of an Escherichia coli dnaA mutation by the integrated R factor R.100.1: Change of chromosome replication origin in synchronized cultures. Journal of Bacteriology 126(3): 1215-1223
Chandler, M.; Silver, L.; Frey, J.; Caro, L. 1977: Suppression of an Escherichia coli dnaA mutation by the integrated R factor R100.1: generation of small plasmids after integration. Journal of Bacteriology 130(1): 303-311
Chandler, M.; Silver, L.; Caro, L. 1977: Suppression of an Escherichia coli dnaA mutation by the integrated R factor R100.1: origin of chromosome replication during exponential growth. Journal of Bacteriology 131(2): 421-430
Overhoff-Freundlieb, B.; Freudl, R. 1991: Suppression of an Escherichia coli secA(ts) mutant by a gene cloned from Staphylococcus carnosus. Fems Microbiology Letters 68(2): 143-149
Díaz Cremades, J.M. 1985: Suppression of an anti-factor VIIi inhibitor using the simultaneous administration of prednisone and factor VIIi. Sangre 30(1): 59-60
Hirota, N.; Ueda, M.; Ozawa, S.; Abe, O.; Shimizu, N. 1989: Suppression of an epidermal growth factor receptor-hyperproducing tumor by an immunotoxin conjugate of gelonin and a monoclonal anti-epidermal growth factor receptor antibody. Cancer Research 49(24 Part 1): 7106-7109
Derr, R.F.; Derr, M. 1985: Suppression of an ethanol withdrawal syndrome in rats by 3-hydroxybutyrate. Life Sciences 36(8): 763-767
Stefani, D.V.; Veltishchev YuE; Semyonov, A.V.; Kudrina, G.P. 1989: Suppression of anaphylactic shock in sensitized guinea pigs by cytochalasin B. Immunology Letters 22(3): 193-194
Momozaki, N.; Oh-Uchida, M.; Tabuchi, K.; Ikezaki, K.; Hori, K. 1992: Suppression of anchorage-independent growth of human glioblastoma cell by major histocompatibility complex class i gene-transfection. Journal of Neurosurgery 76(5): 845-849
Mahana, W.; Guilbert, B.; Avrameas, S. 1987: Suppression of anti-DNA antibody production in MRL mice by treatment with anti-idiotypic antibodies. Clinical and Experimental Immunology 70(3): 538-545
Epstein, A.; Greenberg, M.; Diamond, B.; Grayzel, A.I. 1987: Suppression of anti-DNA antibody synthesis in vitro by a cross-reactive antiidiotypic antibody. Journal of Clinical Investigation 79(3): 997-1000
Mizerski, J.; Noworolski, J.; Zembala, M. 1978: Suppression of anti-hapten (TNP) antibody response by suppressor T cells and their product. the role of macrophages. Archivum Immunologiae et Therapiae Experimentalis 26(1-6): 411-415
Bernstein, A.; Globerson, A. 1977: Suppression of anti-hapten antibody response in vitro by hapten-carrier conjugates. European Journal of Immunology 7(9): 598-602
Kuzel, T.M.; Roenigk, H.H.; Samuelson, E.; Rosen, S.T. 1992: Suppression of anti-interferon alpha-2a antibody formation in patients with mycosis fungoides by exposure to long-wave UV radiation in the a range and methoxsalen ingestion. Journal of the National Cancer Institute 84(2): 119-121
Lowder, J.N.; Miller, R.A.; Hoppe, R.; Levy, R. 1987: Suppression of anti-mouse immunoglobulin antibodies in subhuman primates receiving murine monoclonal antibodies against T cell antigens. Journal of Immunology 138(2): 401-406
Yamane, Y.; Lobo, F.M.; John, L.A.; Edelson, R.L.; Perez, M.I. 1992: Suppression of anti-skin-allograft response by photodamaged effector cells--the modulating effects of prednisolone and cyclophosphamide. Transplantation 54(1): 119-124
Petrov, R.V.; Khaitov, R.M.; Ataullakhanov, R.I.; Sidorovich, I.G. 1977: Suppression of antibody formation by bone marrow B-lymphocytes in spleen cell cultures from mice of different genotypes. Doklady Akademii Nauk SSSR 233(4): 745-748
Gambarov, S.S.; Khaitov, R.M. 1977: Suppression of antibody formation by bone marrow T-cells activated by histocompatibility antigens. Biulleten' Eksperimental'noi Biologii i Meditsiny 83(3): 300-302
Bednarík, T.; Cajthamlová, H. 1978: Suppression of antibody formation in rabbits by administering the alpha globulin fraction of the human plasma and cyclophosphamide. Casopis Lekaru Ceskych 117(48): 1502-1504
Reichard, S.M. 1979: Suppression of antibody forming cells by rat spleen macrophages. Advances in Experimental Medicine and Biology 121(A): 485-495
Cunningham, C.M.; Watson, D.W. 1978: Suppression of antibody response by group a streptococcal pyrogenic exotoxin and characterization of the cells involved. Infection and Immunity 19(2): 470-476
Yasuda, S.I.; Machida, A.; Kumazawa, Y.; Morishita, M.; Mizunoe, K. 1977: Suppression of antibody response in vivo to sheep red blood cells by concanavalin a in mice. Kitasato Archives of Experimental Medicine 50(3-4): 79-85
Terness, P.; Opelz, G. 1985: Suppression of antibody response to transfusions in rats by preconditioning with antibody-coated cells. Transplantation 40(4): 389-393
Lang, G.M.; Kierek-Jaszczuk, D.; Rector, E.S.; Milton, A.D.; Emmrich, F.; Sehon, A.H. 1992: Suppression of antibody responses in rats to murine anti-CD4 monoclonal antibodies by conjugates with monomethoxypolyethylene glycol. Immunology Letters 32(3): 247-252
Johnson, R.J.; Siliciano, R.F.; Shin, H.S. 1979: Suppression of antibody-sensitized tumor cells by macrophages: insufficient supply or activation of macrophages within large tumors. Journal of Immunology 122(2): 379-382
Gasbarre, L.C.; Romanowski, R.D.; Douvres, F.W. 1985: Suppression of antigen- and mitogen-induced proliferation of bovine lymphocytes by excretory-secretory products of Oesophagostomum radiatum. Infection and Immunity 48(2): 540-545
Bianchi, A.T.; Hussaarts-Odijk, L.M.; Wolters, E.A.; Molendijk, A.; Benner, R. 1986: Suppression of antigraft immunity by preimmunization. III. Characterization of suppressor T cells involved in suppression of the efferent phase of DTH against alloantigens. Journal of Immunology 137(2): 433-442
Bril, H.; De Ruiter, H.; Hussaarts-Odijk, L.M.; Bianchi, A.T.; Benner, R. 1985: Suppression of antigraft immunity by preimmunization. IV. Persistence by long-lived recirculating suppressor T cells. Transplantation 40(4): 417-421
Lange, P.H.; Hakala, T.R.; Fraley, E.E. 1976: Suppression of antitumor lymphocyte mediated cytotoxicity by human chorionic gonadotropins. Journal of Urology 115(1): 95-98
Wilson, A.C.; Schaub, R.G.; Goldstein, R.C.; Kuo, P.T. 1990: Suppression of aortic atherosclerosis in cholesterol-fed rabbits by purified rabbit interferon. Arteriosclerosis 10(2): 208-214
Loria, R.M.; Kos, W.L.; Campbell, A.E.; Madge, G.E. 1979: Suppression of aortic elastic tissue autofluorescence for the detection of viral antigen. Histochemistry 61(2): 151-155
Demiroglu, C.; Ozder, A.; Altug, T.; Orbay, B.; Satar-Yíldírím, S.; Bilir, A.; Deniz, G.; Erbengi, T.; Büyükdevrim, S. 1991: Suppression of atherogenesis by n-3 fatty acids in the cholesterol-fed rabbit. Angiology 42(4): 323-330
Lichtor, T.; Davis, H.R.; Vesselinovitch, D.; Wissler, R.W.; Mullan, S. 1989: Suppression of atherogenesis by nifedipine in the cholesterol-fed rhesus monkey. Applied Pathology 7(1): 8-18
Koibuchi, Y.; Sakai, S.; Miura, S.; Ono, T.; Shibayama, F.; Ohtsuka, M. 1989: Suppression of atherogenesis in cholesterol-fed rabbits treated with nilvadipine, a new vasoselective calcium entry blocker. Atherosclerosis 79(2-3): 147-155
Matsushima, T.; Nakashima, Y.; Sugano, M.; Tasaki, H.; Kuroiwa, A.; Koide, O. 1987: Suppression of atherogenesis in hypercholesterolemic rabbits by chondroitin-6-sulfate. Artery 14(6): 316-337
Sugano, M.; Nakashima, Y.; Matsushima, T.; Takahara, K.; Takasugi, M.; Kuroiwa, A.; Koide, O. 1986: Suppression of atherosclerosis in cholesterol-fed rabbits by diltiazem injection. Arteriosclerosis 6(2): 237-241
Kato, J.; Currie, M.G. 1992: Suppression of atrial natriuretic peptide (ANP) receptor recovery from homologous down-regulation by 8-bromo-cGMP in endothelial cells. European Journal of Pharmacology 225(2): 113-117
Puel, J.L.; Bobbin, R.P.; Fallon, M. 1989: Suppression of auditory nerve activity in the guinea pig cochlea by 1-(p-bromobenzoyl)-piperazine-2,3-dicarboxylic acid. Brain Research 487(1): 9-15
Pignone, A.; Matucci-Cerinic, M.; Morfini, M.; Lombardi, A.; Rossi Ferrini, P.L.; Cagnoni, M. 1992: Suppression of autoantibodies to factor VIII and correction of factor VIII deficiency with a combined steroid-cyclophosphamide-porcine factor VIII treatment in a patient with rheumatoid arthritis. Journal of Internal Medicine 231(6): 617-619
Tokuzen, R.; Okabe, M.; Nakahara, W.; Azuma, I.; Yamamura, Y. 1978: Suppression of autochthonous tumors by mixed implantation with Nocardia rubra cell-wall skeleton and related bacterial fractions. Gan 69(1): 19-24
Gershwin, M.E.; Steinberg, A.D. 1975: Suppression of autoimmune hemolytic anemia in New Zealand (NZB) mice by syngeneic young thymocytes. Clinical Immunology and Immunopathology 4(1): 38-45
Morton, R.O.; Goodman, D.G.; Gershwin, M.E.; Derkay, C.; Squire, R.A.; Steinberg, A.D. 1976: Suppression of autoimmunity in NZB mice with steroid-sensitive X-radiation-sensitive syngeneic young thymocytes. Arthritis and Rheumatism 19(6): 1347-1350
Ablin, R.J. 1987: Suppression of autoimmunity to rat male accessory glands: possible relevance to tumor-host responsiveness. American Journal of Reproductive Immunology and Microbiology: Ajrim 13(2): 66-67
Räsänen, L.; Hyöty, H.; Lehto, M.; Kallioniemi, O.P.; Huupponen, T.; Tuomilehto-Wolf, E.; Kaprio, E.; Leinikki, P. 1989: Suppression of autologous mixed leukocyte reaction in type 1 diabetes mellitus by in vivo-activated T lymphocytes. Clinical Immunology and Immunopathology 52(3): 406-413
De Jonge, B.L.; de Lencastre, H.; Tomasz, A. 1991: Suppression of autolysis and cell wall turnover in heterogeneous Tn551 mutants of a methicillin-resistant Staphylococcus aureus strain. Journal of Bacteriology 173(3): 1105-1110
Ofek, I.; Beachey, E.H.; Eisenstein, B.I.; Alkan, M.L.; Sharon, N. 1979: Suppression of bacterial adherence by subminimal inhibitory concentrations of beta-lactam and aminoglycoside antibiotics. Reviews of Infectious Diseases 1(5): 832-837
Allen, J.B.; Bansal, G.P.; Feldman, G.M.; Hand, A.O.; Wahl, L.M.; Wahl, S.M. 1991: Suppression of bacterial cell wall-induced polyarthritis by recombinant gamma interferon. Cytokine 3(2): 98-106
Brand, K.G.; Boen, J.R.; Van Pilsum, J.F. 1975: Suppression of bacterial growth and ammonia formation by citrate buffer in urine collected in ileal loop receptacles. Urology 6(6): 738-740
Ghoneum, M.; Gill, G.; Wojdani, A.; Payne, C.; Alfred, L.J. 1987: Suppression of basal and Corynebacterium parvum-augmented NK activity during chemically induced tumor development. International Journal of Immunopharmacology 9(1): 71-78
Hiatt, E.S.; Schwartz, N.B. 1989: Suppression of basal and GnRH-stimulated gonadotropin secretion rate in vitro by GnRH antagonist: differential effects on metestrous and proestrous pituitaries. Neuroendocrinology 50(2): 158-164
Newman, C.B.; Wardlaw, S.L.; Frantz, A.G. 1985: Suppression of basal and stress-induced prolactin release and stimulation of luteinizing hormone secretion by alpha-melanocyte-stimulating hormone. Life Sciences 36(17): 1661-1668
Schürmeyer, T.H.; Gallucci, B.T.; Tomai, T.P. 1988: Suppression of basal plasma cortisol and adrenal androgen concentrations, but not of ACTH and cortisol responses to hCRH by low-dose dexamethasone in rhesus monkeys. Journal of Steroid Biochemistry 30(1-6): 435-437
Bratusch-Marrain, P.R.; Waldhäusl, W.K. 1985: Suppression of basal, but not of glucose-stimulated insulin secretion by human insulin in healthy and obese hyperinsulinemic subjects. Metabolism, Clinical and Experimental 34(2): 188-193
Pottala, E.W.; Bailey, J.J.; Horton, M.R.; Gradwohl, J.R. 1989: Suppression of baseline wander in the ECG using a bilinearly transformed, null-phase filter. Journal of Electrocardiology 22 Suppl: 243-247
Bergman, J.; Glowa, J.R. 1986: Suppression of behavior by food pellet-lithium chloride pairings in squirrel monkeys. Pharmacology Biochemistry and Behavior 25(5): 973-978
Schaefer, R.M.; Paczek, L.; Heidland, A. 1991: Suppression of beta 2-microglobulin release from lymphocytes by dialysis membranes. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 6(Suppl 3): 53-56
de Carvalho, F.; Gheysen, G.; Kushnir, S.; Van Montagu, M.; Inzé, D.; Castresana, C. 1992: Suppression of beta-1,3-glucanase transgene expression in homozygous plants. EMBO Journal 11(7): 2595-2602
Galbraith, R.A.; Drummond, G.S.; Kappas, A. 1992: Suppression of bilirubin production in the Crigler-Najjar type i syndrome: studies with the heme oxygenase inhibitor tin-mesoporphyrin. Pediatrics 89(2): 175-182
Mortola, J.F.; Sathanandan, M.; Pavlou, S.; Dahl, K.D.; Hsueh, A.J.; Rivier, J.; Vale, W.; Yen, S.S. 1989: Suppression of bioactive and immunoreactive follicle-stimulating hormone and luteinizing hormone levels by a potent gonadotropin-releasing hormone antagonist: pharmacodynamic studies. Fertility and Sterility 51(6): 957-963
Rodloff, A.C.; Widera, P.; Ehlers, S.; Montag, T.; Lucas, M.; Schmidt, G.; Hahn, H. 1990: Suppression of blastogenic transformation of lymphocytes by Bacteroides fragilis in vitro and in vivo. Zentralblatt für Bakteriologie: International Journal of Medical Microbiology 274(3): 406-416
Matsuzaki, A.; Shiroki, K.; Kimura, G. 1988: Suppression of block to entry into S phase in cell-cycle mutants of rat 3Y1 fibroblasts after transformation by adenovirus type 12. Virology 165(1): 57-65
Gross, S.; Worthington-White, D.A.; Fennell, R.S. 1991: Suppression of bone marrow by low-density lipoproteins in renal disease patients. American Journal of Pediatric Hematology/Oncology 13(3): 258-262
Egawa, S.; Tsukiyama, I.; Akine, Y.; Kajiura, Y.; Ogino, T. 1987: Suppression of bony growth of the orbit after radiotherapy for retinoblastoma. Radiation Medicine 5(6): 207-211
Baumann, R.J.; Hanson, W.L.; McCann, P.P.; Sjoerdsma, A.; Bitonti, A.J. 1990: Suppression of both antimony-susceptible and antimony-resistant Leishmania donovani by a bis(benzyl)polyamine analog. Antimicrobial Agents and ChemoTherapy 34(5): 722-727
Gallily, R.; Gifford, G.E.; Loewenstein, J. 1986: Suppression of both macrophage-mediated tumor cell lysis and cytolytic factor production by a factor (CIF) derived from normal embryonic fibroblasts. Cancer Immunology Immunotherapy: Cii 23(1): 60-66
Duchen, L.W.; Rogers, M.; Stolkin, C.; Tonge, D.A. 1975: Suppression of botulinum toxin-induced axonal sprouting in skeletal muscle by implantation of an extra nerve. Journal of Physiology 248(1): 1p-2p
Kimijima, I.; Urazumi, K.; Tsuchiya, A.; Abe, R. 1992: Suppression of breast cancer cells by cardiac glycosides. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(9): 1399-1402
Kurachi, M.; Hongoh, K.; Watanabe, A.; Aihara, H. 1987: Suppression of bronchial response to platelet activating factor following taurine administration. Advances in Experimental Medicine and Biology 217: 189-198
Huang, T.S.; Lee, S.C.; Lin, J.K. 1991: Suppression of c-Jun/AP-1 activation by an inhibitor of tumor promotion in mouse fibroblast cells. Proceedings of the National Academy of Sciences of the United States of America 88(12): 5292-5296
Harbers, M.; Hilz, H. 1991: Suppression of c-fos precursor RNA splicing by the protein kinase C inhibitor H7 [1-(5-isoquinolinesulphonyl)-2-methylpiperazine. Biochemical Journal 278: 305-308
Ogiso, Y.; Kitagawa, K.; Nishino, H.; Iwashima, A.; Shudo, K. 1987: Suppression of c-mos expression in teratocarcinoma cells with a new type of inducer of differentiation, 3,5-di-tert-butylchalcone 4'-carboxylic acid. Experimental Cell Research 173(1): 262-266
Schachner, J.; Blick, M.; Freireich, E.; Gutterman, J.; Beran, M. 1988: Suppression of c-myc and c-myb expression in myeloid cell lines treated with recombinant tumor necrosis factor-alpha. Leukemia 2(11): 749-753
Hoffman-Liebermann, B.; Liebermann, D.A. 1991: Suppression of c-myc and c-myb is tightly linked to terminal differentiation induced by IL6 or LIF and not growth inhibition in myeloid leukemia cells. Oncogene 6(6): 903-909
Koizumi, T.; Nakao, Y.; Kawanishi, M.; Maeda, S.; Sugiyama, T.; Fujita, T. 1989: Suppression of c-myc mRNA expression by steroid hormones in HTLV-I-infected T-cell line, KH-2. International Journal of Cancer 44(4): 701-706
Reyland, M.E.; Williams, D.L. 1991: Suppression of cAMP-mediated signal transduction in mouse adrenocortical cells which express apolipoprotein e. Journal of Biological Chemistry 266(31): 21099-21104
Chan, C.T.; Wells, H.; Kramsch, D.M. 1978: Suppression of calcific fibrous-fatty plaque formation in rabbits by agents not affecting elevated serum cholesterol levels. the effect of thiophene compounds. Circulation Research 43(1): 115-125
Murphy, J.M.; Mashman, J.; Miller, J.D.; Bell, J.B. 1991: Suppression of carbamazepine-induced rash with prednisone. Neurology 41(1): 144-145
Posselt, A.M.; Kwong, L.K.; Vreman, H.J.; Stevenson, D.K. 1986: Suppression of carbon monoxide excretion rate by tin protoporphyrin. American Journal of Diseases of Children 140(2): 147-150
Sporn, M.B.; Roberts, A.B. 1985: Suppression of carcinogenesis by retinoids: interactions with peptide growth factors and their receptors as a key mechanism. Princess Takamatsu Symposia 16: 149-158
Wakefield, L.M.; Sporn, M.B. 1990: Suppression of carcinogenesis: a role for TGF-beta and related molecules in prevention of cancer. Immunology Series 51: 217-243
Petin, G.I.; Strelets, B.M.; Krasavin, V.A. 1989: Suppression of cardiac activity and respiration during conduction anesthesia. Vestnik Khirurgii Imeni I. I. Grekova 142(5): 129
Oyanagui, Y.; Sato, S. 1991: Suppression of carrageenan paw oedema in rats and mice by heparin-induced EC-SODs. Free Radical Research Communications: 12-13 Pt 1: 229-237
Costello, A.H.; Hargreaves, K.M. 1989: Suppression of carrageenan-induced hyperalgesia, hyperthermia and edema by a bradykinin antagonist. European Journal of Pharmacology 171(2-3): 259-263
Ceremuzyński, L.; Lada, W.; Maruchin, J.; Dluzniewski, M.; Herbacyńska-Cedro, K. 1979: Suppression of catecholamine excretion by low doses of clonidine in healthy subjects and feasibility study on clonidine application in angina pectoris. Arzneimittel-Forschung 29(5): 829-835
Hasegawa, J.; Matsumoto, T.; Takami, T.; Fujimoto, Y.; Kotake, H.; Mashiba, H. 1989: Suppression of catecholamine-induced abnormal pacemaker activities by magnesium ion in guinea pig cardiac muscle cells. Magnesium 8(2): 94-99
Hellström, I.; Hellström, K.E.; Kall, M.A.; Nelson, K.; Pollack, S. 1976: Suppression of cell-mediated cytotoxicity by lymphocytes from tumor-bearing animals. Transplantation Proceedings 8(2): 255-264
Baba, T.; Yoshida, T.; Yoshida, T.; Cohen, S. 1979: Suppression of cell-mediated immune reactions by monosaccharides. Journal of Immunology 122(3): 838-841
Riley, E.M.; Schneider, G.; Sambou, I.; Greenwood, B.M. 1989: Suppression of cell-mediated immune responses to malaria antigens in pregnant Gambian women. American Journal of Tropical Medicine and Hygiene 40(2): 141-144
Ganguly, R.; Cusumano, C.L.; Waldman, R.H. 1976: Suppression of cell-mediated immunity after infection with attenuated rubella virus. Infection and Immunity 13(2): 464-469
Grove, D.I.; Mahmound, A.A.; Warren, K.S. 1977: Suppression of cell-mediated immunity by metronidazole. International Archives of Allergy and Applied Immunology 54(5): 422-427
Ghosh, R.C.; Chauhan, H.V.; Jha, G.J. 1991: Suppression of cell-mediated immunity by purified aflatoxin B1 in broiler chicks. Veterinary Immunology and Immunopathology 28(2): 165-172
Wiktor, T.J.; Doherty, P.C.; Koprowski, H. 1977: Suppression of cell-mediated immunity by street rabies virus. Journal of Experimental Medicine 145(6): 1617-1622
Reed, S.G.; Larson, C.L.; Speer, C.A. 1977: Suppression of cell-mediated immunity in experimental Chagas' disease. Zeitschrift für Parasitenkunde 52(1): 11-17
Scornik, J.C.; Ruiz, P.; Hoffman, E.M. 1979: Suppression of cell-mediated tumor cell lysis and complement-induced cytotoxicity by trypan blue. Journal of Immunology 123(3): 1278-1284
Van der Eb, A.J.; Timmers, H.T.; Offringa, R.; Zantema, A.; van den Heuvel, S.J.; van Dam, J.A.; Bos, J.L. 1989: Suppression of cellular gene activity in adenovirus-transformed cells. Current Topics in Microbiology and Immunology 144: 197-207
Nishida, Y.; Kamatani, N.; Tanimoto, K.; Akaoka, I. 1979: Suppression of cellular immunity due to inhibition of purine nucleoside phosphorylase by allopurinol-riboside. Advances in Experimental Medicine and Biology 122b: 309-313
Greve, J.W.; Gouma, D.J.; Soeters, P.B.; Buurman, W.A. 1990: Suppression of cellular immunity in obstructive jaundice is caused by endotoxins: a study with germ-free rats. Gastroenterology 98(2): 478-485
Marinova-Mutafchieva, L.P.; Chakalova, G.B.; Goranov, I.T. 1991: Suppression of cellular immunity in patients with carcinoma in situ and microinvasive cancer of the cervix uteri. Voprosy Onkologii 37(4): 454-457
Nishihira, Y.; Araki, H.; Ishihara, A. 1990: Suppression of cerebral evoked potentials preceding rapid reaction movement. Journal of Sports Medicine and Physical Fitness 30(3): 291-296
Schwabedal, P.E.; Brügging-Schmitz, G.; Oestreich, W.; Szathmary, S.C. 1989: Suppression of cerebral, myocardial and renal arteriosclerosis by the calcium antagonist flunarizine in hypertensive rats (Skelton model) without reduction of the high blood pressure. Journal of Hypertension. Supplement: Official Journal of the International Society of Hypertension 7(6): S280-S281
Hui, C.S.; Milton, R.L. 1987: Suppression of charge movement in frog skeletal muscle by D600. Journal of Muscle Research and Cell Motility 8(3): 195-208
Pottathil, R.; Huebner, R.J.; Meier, H. 1978: Suppression of chemical (DEN) carcinogenesis in SWR/J mice by goat antibodies against endogenous murine leukemia viruses. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 159(1): 65-68
Pruzanski, W.; Nitzan, D.W.; Saito, S. 1986: Suppression of chemotactic activity of human polymorphonuclears by monoclonal IgMs with and without biological activity. American Journal of Hematology 23(1): 31-42
Rabinovich, S.A.; Kulikovskaia, I.M.; Maksakovskaia, E.V.; Chekhonadskikh, T.V.; Pankova, T.G. 1986: Suppression of chloroquine resistance in Plasmodium berghei by using a microsomal monooxygenase inhibitor. Meditsinskaia Parazitologiia i Parazitarnye Bolezni 4: 7-10
Van der Schroeff, J.G.; Havekes, L.; Weerheim, A.M.; Emeis, J.J.; Vermeer, B.J. 1985: Suppression of cholesteryl ester accumulation in cultured human monocyte-derived macrophages by lipoxygenase inhibitors. Biochemical and Biophysical Research Communications 127(1): 366-372
Takiyyuddin, M.A.; Baron, A.D.; Cervenka, J.H.; Barbosa, J.A.; Neumann, H.P.; Parmer, R.J.; Sullivan, P.A.; O'Connor, D.T. 1991: Suppression of chromogranin-A release from neuroendocrine sources in man: pharmacological studies. Journal of Clinical Endocrinology and Metabolism 72(3): 616-622
Uemura, H.; Wickner, R.B. 1988: Suppression of chromosomal mutations affecting M1 virus replication in Saccharomyces cerevisiae by a variant of a viral RNA segment (L-A) that encodes coat protein. Molecular and Cellular Biology 8(2): 938-944
Yoshino, S.; Yoshino, J. 1992: Suppression of chronic antigen-induced arthritis in rats by a monoclonal antibody against the T cell receptor alpha beta. Cellular Immunology 144(2): 382-391
Estrov, Z.; Kurzrock, R.; Wetzler, M.; Kantarjian, H.; Blake, M.; Harris, D.; Gutterman, J.U.; Talpaz, M. 1991: Suppression of chronic myelogenous leukemia colony growth by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors: a novel application for inhibitors of IL-1 activity. Blood 78(6): 1476-1484
Hubert, G.D.; Schriock, E.D.; Givens, J.R.; Buster, J.E. 1991: Suppression of circulating delta 4-androstenedione and dehydroepiandrosterone sulfate during oral glucose tolerance test in normal females. Journal of Clinical Endocrinology and Metabolism 73(4): 781-784
Versteeg, R.; Krüse-Wolters, K.M.; Plomp, A.C.; van Leeuwen, A.; Stam, N.J.; Ploegh, H.L.; Ruiter, D.J.; Schrier, P.I. 1989: Suppression of class i human histocompatibility leukocyte antigen by c-myc is locus specific. Journal of Experimental Medicine 170(3): 621-635
Koh, C.S.; Paterson, P.Y. 1987: Suppression of clinical signs of cell-transferred experimental allergic encephalomyelitis and altered cerebrovascular permeability in Lewis rats treated with a plasminogen activator inhibitor. Cellular Immunology 107(1): 52-63
Watanabe, T.; Suga, T. 1988: Suppression of clofibrate-induced peroxisome proliferation in rat liver by nicardipine, a calcium antagonist. Febs Letters 232(2): 293-297
Talpaz, M.; Trujillo, J.M.; Hittelman, W.N.; Keating, M.J.; Gutterman, J.U. 1985: Suppression of clonal evolution in two chronic myelogenous leukaemia patients treated with leucocyte interferon. British Journal of Haematology 60(4): 619-624
Zanoboni, A.; Zanoboni-Muciaccia, W.; Zanussi, C.; Baraldi, R. 1979: Suppression of clonidine-induced release of growth hormone by thyrotropin releasing hormone in humans. Journal of Endocrinological Investigation 2(4): 347-351
Kawarai, M.; Chiba, S. 1988: Suppression of clonidine-induced vasoconstriction by cooling. Japanese Journal of Pharmacology 48(4): 510-512
Imai-Matsumara, K.; Matsumura, K.; Morimoto, A.; Nakayama, T. 1990: Suppression of cold-induced thermogenesis in full-term pregnant rats. Journal of Physiology 425: 271-281
Szabo, M.; Frohman, L.A. 1977: Suppression of cold-stimulated thyrotropin secretion by antiserum to thyrotropin-releasing hormone. Endocrinology 101(4): 1023-1033
Al-Nakib, W.; Higgins, P.G.; Barrow, G.I.; Tyrrell, D.A.; Andries, K.; Vanden Bussche, G.; Taylor, N.; Janssen, P.A. 1989: Suppression of colds in human volunteers challenged with rhinovirus by a new synthetic drug (R61837). Antimicrobial Agents and ChemoTherapy 33(4): 522-525
Arita, C.; Kaibara, N.; Jingushi, S.; Takagishi, K.; Hotokebuchi, T.; Arai, K. 1987: Suppression of collagen arthritis in rats by heterologous anti-idiotypic antisera against anticollagen antibodies. Clinical Immunology and Immunopathology 43(3): 374-381
Peacock, D.J.; Ku, G.; Banquerigo, M.L.; Brahn, E. 1992: Suppression of collagen arthritis with antibodies to an arthritogenic, oligoclonal T cell line. Cellular Immunology 140(2): 444-452
Burrai, I.; Henderson, B.; Knight, S.C.; Staines, N.A. 1985: Suppression of collagen type II-induced arthritis by transfer of lymphoid cells from rats immunized with collagen. Clinical and Experimental Immunology 61(2): 368-372
Brahn, E.; Peacock, D.J.; Banquerigo, M.L. 1991: Suppression of collagen-induced arthritis by combination cyclosporin A and methotrexate therapy. Arthritis and Rheumatism 34(10): 1282-1288
Thompson, H.S.; Staines, N.A. 1986: Suppression of collagen-induced arthritis with pergastrically or intravenously administered type II collagen. Agents and Actions 19(5-6): 318-319
Kawaura, A.; Tanida, T.; Sawada, K.; Oda, M.; Shimoyama, T. 1992: Suppression of colonic carcinogenesis by vitamin D in rats. Journal of Nutritional Science and Vitaminology Spec No: 331-332
Asghar, S.S.; Dingemans, K.P.; Kammeijer, A.; Faber, W.R.; Abdel Mawla, M.Y. 1986: Suppression of complement-mediated vascular injury at Arthus reaction sites by complement inhibitors. Complement 3(1): 40-48
Gnecchi, M.; De Marzio, P.; Morelli, S.; Aguglia, F. 1985: Suppression of complex ventricular arrhythmias with isosorbide dinitrate in a case of congestive heart failure. Cardiologia 30(5): 401-404
Sandstrom, E.G.; Andrews, C.; Schooley, R.T.; Byington, R.; Hirsch, M.S. 1986: Suppression of concanavalin A-induced blastogenesis by HTLV-III-infected H9 cells. Clinical Immunology and Immunopathology 40(2): 253-258
Yokono, K.; Kawase, Y.; Nagata, M.; Hatamori, N.; Baba, S. 1989: Suppression of concanavalin A-induced responses in splenic lymphocytes by activated macrophages in the non-obese diabetic mouse. Diabetologia 32(1): 67-73
Fassolt, A.; Braun, U.; Schaefler, O. 1975: Suppression of concomitant thrombosis in central venous catheters (infraclavicular route) by salicylates. Der Anaesthesist 24(7): 325-328
Wadenberg, M.L.; Ericson, E.; Magnusson, O.; Ahlenius, S. 1990: Suppression of conditioned avoidance behavior by the local application of (-)sulpiride into the ventral, but not the dorsal, striatum of the rat. Biological Psychiatry 28(4): 297-307
Wadenberg, M.L.; Ahlenius, S. 1988: Suppression of conditioned avoidance by 8-OH-DPAT in the rat. Journal of Neural Transmission 74(3): 195-198
Fatechand, R. 1978: Suppression of cone signal in the dark-adapted frog retina as indicated by the electroretinogram. Revue Canadienne de Biologie 37(2): 101-113
Dong, C.J.; Qian, H.H.; McReynolds, J.S.; Yang, X.L.; Liu, Y.M. 1988: Suppression of cone-driven responses by rods in the isolated frog retina. Visual Neuroscience 1(4): 331-338
Morgan, E.T. 1989: Suppression of constitutive cytochrome P-450 gene expression in livers of rats undergoing an acute phase response to endotoxin. Molecular Pharmacology 36(5): 699-707
Harriott-Smith, T.G.; Halliday, W.J. 1988: Suppression of contact hypersensitivity by short-term ultraviolet irradiation: I. Immunosuppression by serum from irradiated mice. Clinical and Experimental Immunology 71(1): 144-148
Harriott-Smith, T.G.; Halliday, W.J. 1988: Suppression of contact hypersensitivity by short-term ultraviolet irradiation: II. the role of urocanic acid. Clinical and Experimental Immunology 72(1): 174-177
Lio, D.; Dieli, F.; Cillari, E.; Salerno, A. 1987: Suppression of contact sensitivity by a plastic adherent T-cell, induced in mice infected with Newcastle disease virus (NDV). British Journal of Experimental Pathology 68(5): 663-674
Yoshioka, A.; Miyachi, Y.; Imamura, S.; Hiraoka, M.; Jo, S.; Abe, M. 1989: Suppression of contact sensitivity by local hyperthermia treatment due to reduced Langerhans cell population in mice. British Journal of Dermatology 120(4): 493-501
Kobayashi, C.; Kanai, A.; Nakajima, A.; Okumura, K. 1989: Suppression of corneal graft rejection in rabbits by a new immunosuppressive agent, FK-506. Transplantation Proceedings 21(1 Part 3): 3156-3158
Schwabedal, P.E.; Oestreich, W.; Szathmary, S.C. 1989: Suppression of coronary sclerosis in hypertensive rats by calcium channel antagonists without lowering blood pressure. Zeitschrift für Kardiologie 78 Suppl. 5: 108-111
Dubourdieu, S.; Charbonnel, B.; Massai, M.R.; Marraoui, J.; Spitz, I.; Bouchard, P. 1991: Suppression of corpus luteum function by the gonadotropin-releasing hormone antagonist Nal-Glu: effect of the dose and timing of human chorionic gonadotropin administration. Fertility and Sterility 56(3): 440-445
Rist, T.; Ruggles, C.W.; Ryan, M.E.; Garcia, R.L.; Osborne, D. 1978: Suppression of corticosteroid-induced atrophy and telangiectasia with vitamin a. Archives of Dermatology 114(4): 624
Fan, S.F.; Dewey, M.M.; Chu, B. 1992: Suppression of crossbridge motions of isolated thick myofilaments in ATP-free medium by thiourea. Biochemical and Biophysical Research Communications 186(1): 321-326
Nantulya, V.M.; Moloo, S.K. 1988: Suppression of cyclical development of Trypanosoma brucei brucei in Glossina morsitans centralis by an anti-procyclics monoclonal antibody. Acta Tropica 45(2): 137-144
Tang, M.S.; Htun, H.; Cheng, Y.; Dahlberg, J.E. 1991: Suppression of cyclobutane and mean value of 6-4 dipyrimidines formation in triple-stranded H-DNA. Biochemistry 30(28): 7021-7026
Lin, Y.S.; Patel, M.R.; Linna, T.J.; Rogers, T.J. 1986: Suppression of cytolytic T-cell activity by staphylococcal enterotoxin B-induced suppressor cells: role of interleukin 2. Cellular Immunology 103(1): 147-159
Degiovanni, G. 1987: Suppression of cytolytic T-lymphocyte responses through inactivation of non-T accessory cells. Scandinavian Journal of Immunology 25(5): 453-460
House, R.V.; Pallardy, M.J.; Cornacoff, J.B.; Thurmond, L.M.; Dean, J.H. 1989: Suppression of cytolytic function in murine lymphocytes exposed to 1,4-bis[(2-aminoethyl)amino]-5,8-dihydroxy-9,10-anthracenedione dihydrochloride (AEAD): inhibition of proliferation by cytotoxic T-lymphocyte precursors. International Journal of Immunopharmacology 11(3): 301-308
Sha, B.E.; Benson, C.A.; Deutsch, T.A.; Urbanski, P.A.; Phair, J.P.; Kessler, H.A. 1991: Suppression of cytomegalovirus retinitis in persons with AIDS with high-dose intravenous acyclovir. Journal of Infectious Diseases 164(4): 777-780
Tomono, M.; Urayama, T. 1990: Suppression of cytoplasmic Ca2+ response and protein secretion by oxidizing agents. Japanese Journal of Experimental Medicine 60(6): 337-342
Griffiths, A.J.; Xiao, Y.; Barton, R.; Myers, C. 1992: Suppression of cytoplasmic senescence in Neurospora. Current Genetics 21(6): 479-484
Grimminger, F.; Sibelius, U.; Aktories, K.; Just, I.; Seeger, W. 1991: Suppression of cytoskeletal rearrangement in activated human neutrophils by botulinum C2 toxin. Impact on cellular signal transduction. Journal of Biological Chemistry 266(29): 19276-19282
O'Hara, R.M.; Bitter-Suermann, H.; Duncan, W.R. 1985: Suppression of cytotoxic T cell activity in the Syrian hamster. Transplantation Proceedings 17(4): 1987-1990
Nakamura, A.; Magae, J.; Tsuji, R.F.; Yamasaki, M.; Nagai, K. 1989: Suppression of cytotoxic T cell induction in vivo by prodigiosin 25-C. Transplantation 47(6): 1013-1016
Arora, P.K.; Hanna, E.E.; Skolnick, P. 1991: Suppression of cytotoxic T lymphocyte (CTL) activity by FG 7142, a benzodiazepine receptor 'inverse agonist'. Immunopharmacology 21(2): 91-97
Dröge, W.; Männel, D.; Falk, W.; Lehmann, V.; Schmidt, H.; Nick, S.; Häcker-Shahin, B.; Jänicke, R. 1985: Suppression of cytotoxic T lymphocyte activation by L-ornithine. Journal of Immunology 134(5): 3379-3383
Choi, K.L.; Maier, T.; Holda, J.H.; Claman, H.N. 1988: Suppression of cytotoxic T-cell generation by natural suppressor cells from mice with GVHD is partially reversed by indomethacin. Cellular Immunology 112(2): 271-278
Mihm, S.; Dröge, W. 1986: Suppression of cytotoxic T-lymphocyte activation by pyruvate and L-alanine. Cellular Immunology 99(2): 313-321
Bazanova, E.A.; Gnezditskaia, E.V.; Liampert, I.M.; Borodiiuk, N.A.; Evseeva, L.F.; Spirina, G.V.; Asoskova, T.K. 1990: Suppression of cytotoxic cellular reactions by the production of antibodies to rhamnose determinants of streptococcal group a polysaccharide cross-reacting with antigens of the skin epithelium. Biulleten' Eksperimental'noi Biologii i Meditsiny 110(8): 170-172
Truitt, G.A.; Rich, R.R.; Rich, S.S. 1978: Suppression of cytotoxic lymphocyte responses in vitro by soluble products of alloantigen-activated spleen cells. Journal of Immunology 121(3): 1045-1051
Gorczynski, R.M.; MacRae, S. 1979: Suppression of cytotoxic response to histoincompatible cells. I. Evidence for two types of T lymphocyte-derived suppressors acting at different stages in the induction of a cytotoxic response. Journal of Immunology 122(3): 737-746
Gorczynski, R.M.; MacRae, S. 1979: Suppression of cytotoxic response to histoincompatible cells. II. Analysis of the role of two independent T suppressor pools in maintenance of neonatally induced allograft tolerance in mice. Journal of Immunology 122(3): 747-752
Teh, H.S.; Ho, M.; Williams, L.D. 1988: Suppression of cytotoxic responses by a supernatant factor derived from Mycoplasma hyorhinis-infected mammalian cell lines. Infection and Immunity 56(1): 197-203
Anderson, R.J.; Raines, A. 1976: Suppression of decerebrate rigidity by phenytoin and chlorpromazine. Neurology 26(9): 858-862
Leung, A.; Rubinstein, S.; Yang, C.; Li, J.W.; Leighton, T. 1985: Suppression of defective-sporulation phenotypes by mutations in the major sigma factor gene (rpoD) of Bacillus subtilis. Molecular and General Genetics: Mgg 201(1): 96-98
Ng, C.; Buchanan, C.; Leung, A.; Ginther, C.; Leighton, T. 1991: Suppression of defective-sporulation phenotypes by mutations in transcription factor genes of Bacillus subtilis. Biochimie 73(7-8): 1163-1170
Kruck, T.P.; Fisher, E.A.; McLachlan, D.R. 1990: Suppression of deferoxamine mesylate treatment-induced side effects by coadministration of isoniazid in a patient with Alzheimer's disease subject to aluminum removal by ionspecific chelation. Clinical Pharmacology and Therapeutics 48(4): 439-446
McGuire, R.L.; Fox, R.A. 1979: Suppression of delayed hypersensitivity by the depletion of circulating monocytes. Immunology 38(1): 157-161
Chernousov, A.D.; Fontalin, L.N. 1979: Suppression of delayed hypersensitivity in mice receiving a massive dose of xenogeneic erythrocytes. Biulleten' Eksperimental'noi Biologii i Meditsiny 88(12): 693-695
Sengupta, U.; Sinha, S.; Ramu, G.; Lamb, J.; Ivanyi, J. 1987: Suppression of delayed hypersensitivity skin reactions to tuberculin by M. leprae antigens in patients with lepromatous and tuberculoid leprosy. Clinical and Experimental Immunology 68(1): 58-64
Akopian, N.G.; Bekhalo, V.A.; Liadova, I.V.; Fontalin, L.N. 1989: Suppression of delayed hypersensitivity to microbial and transplantation antigens with ultraviolet radiation. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 6: 81-83
Neveu, P.J. 1978: Suppression of delayed hypersensitivity to the hapten by induction of tolerance to the carrier. International Archives of Allergy and Applied Immunology 57(2): 126-129
Machida, A.; Yasuda, S.; Kumazawa, Y.; Mizunoe, K. 1977: Suppression of delayed type hypersensitivity induction to sheep red blood cells by concanavalin a in mice. International Archives of Allergy and Applied Immunology 54(2): 158-164
Müller, S.; Gillert, K.E.; Krause, C.; Gross, U.; Age-Stehr, J.L.; Diamantstein, T. 1977: Suppression of delayed type hypersensitivity of mice by lead. Experientia 33(5): 667-668
Lathey, J.L.; Martin, S.; Rouse, B.T. 1987: Suppression of delayed type hypersensitivity to herpes simplex virus type 1 following immunization with anti-idiotypic antibody: an example of split tolerance. Journal of General Virology 68: 1093-1102
Tajima, S.; Nishimura, N.; Ito, K. 1985: Suppression of delayed-type hypersensitivity mediated by macrophage-like cells in mice with experimental liver injury. Immunology 54(1): 57-64
Murai, K.; Tachibana, N.; Shioiri, S.; Shishime, E.; Okayama, A.; Ishizaki, J.; Tsuda, K.; Mueller, N. 1990: Suppression of delayed-type hypersensitivity to PPD and PHA in elderly HTLV-I carriers. Journal of Acquired Immune Deficiency Syndromes 3(10): 1006-1009
Molendijk, A.; van Gurp, R.J.; Donselaar, I.G.; Benner, R. 1987: Suppression of delayed-type hypersensitivity to histocompatibility antigens by ultraviolet radiation. Immunology 62(2): 299-305
Swartz, R.P. 1986: Suppression of delayed-type hypersensitivity to radiation [UV, 280-320 nm (UVB)]-induced tumor cells with serum factors from UVB-irradiated mice. Journal of the National Cancer Institute 76(6): 1181-1184
Sakamoto, Y.; Nomoto, K. 1986: Suppression of delayed-type hypersensitivity to syngeneic testicular cells in mice: involvement of suppressor T cells which act at the induction stage. Cellular Immunology 102(1): 168-176
Hyodo, M.; Suzuki, K.; Tsuda, M. 1989: Suppression of deoxyguanosine cytotoxicity and deoxyguanosine kinase activity in mouse FM3A mammary carcinoma cell: mutants defective in hypoxanthine phosphoribosyl-transferase. Tokai Journal of Experimental and Clinical Medicine 14(1): 5-14
Brown, D.R.; Holtzman, S.G. 1979: Suppression of deprivation-induced food and water intake in rats and mice by naloxone. Pharmacology Biochemistry and Behavior 11(5): 567-573
Ukai, M.; Holtzman, S.G. 1987: Suppression of deprivation-induced water intake in the rat by opioid antagonists: central sites of action. Psychopharmacology 91(3): 279-284
Rodriguez-Alfageme, C.; Stanbridge, E.J.; Astrin, S.M. 1992: Suppression of deregulated c-MYC expression in human colon carcinoma cells by chromosome 5 transfer. Proceedings of the National Academy of Sciences of the United States of America 89(4): 1482-1486
Tononi, G.; Pompeiano, M.; Cirelli, C. 1991: Suppression of desynchronized sleep through microinjection of the alpha 2-adrenergic agonist clonidine in the dorsal pontine tegmentum of the cat. Pflugers Archiv: European Journal of Physiology 418(5): 512-518
Artemova, E.P.; Nugmanova, L.B. 1991: Suppression of development of autoimmune thyroiditis during prolonged stimulation of T-cellular immunity. Problemy Endokrinologii 37(5): 44-47
Basu, A.; Lazo, J.S. 1991: Suppression of dexamethasone-induced metallothionein expression and cis-diamminedichloroplatinum(II) resistance by v-mos. Cancer Research 51(3): 893-896
Kirsten, E.; Bauer, P.I.; Kun, E. 1991: Suppression of dexamethasone-stimulated DNA synthesis in an oncogene construct containing rat cell line by a DNA site-oriented ligand of poly-ADP-ribose polymerase: 6-amino-1,2-benzopyrone. Experimental Cell Research 193(1): 1-4
Hasegawa, R.; Tiwawech, D.; Hirose, M.; Takaba, K.; Hoshiya, T.; Shirai, T.; Ito, N. 1992: Suppression of diethylnitrosamine-initiated preneoplastic foci development in the rat liver by combined administration of four antioxidants at low doses. Japanese Journal of Cancer Research: Gann 83(5): 431-437
Suzuki, K.; Suzuki, F.; Nikaido, O.; Watanabe, M. 1991: Suppression of differentiation phenotypes in myogenic cells: association of aneuploidy and altered regulation of c-myc gene expression. Experimental Cell Research 195(2): 416-422
St Clair, W.H.; Billings, P.C.; Carew, J.A.; Keller-McGandy, C.; Newberne, P.; Kennedy, A.R. 1990: Suppression of dimethylhydrazine-induced carcinogenesis in mice by dietary addition of the Bowman-Birk protease inhibitor. Cancer Research 50(3): 580-586
Couch, D.B.; Friedman, M.A. 1976: Suppression of dimethylnitrosamine mutagenicity by nitrososarcosine and other nitrosamines. Mutation Research 38(2): 89-96
Maki, H.; Bryan, S.K.; Horiuchi, T.; Moses, R.E. 1989: Suppression of dnaE nonsense mutations by pcbA1. Journal of Bacteriology 171(6): 3139-3143
Oskolkova, O.B.; Piruzian, E.S. 1988: Suppression of dnaZ mutation during integration of factor F' into the chromosome of a mutant strain. Genetika 24(4): 622-627
Polijak-Blazi, M.; Hadzija, M. 1987: Suppression of donor lymphocyte reactivity by pretreatment with recipient type UV-irradiated blood. Transplantation Proceedings 19(1 Part 2): 944-945
Daniel, V.; Opelz, G. 1988: Suppression of donor-reactive T cells by pretransplant sera of renal transplant recipients. Transplantation Proceedings 20(2): 291-292
Marques-Assis, L. 1977: Suppression of drug therapy in epilepsies. Arquivos de Neuro-Psiquiatria 35(2): 112-118
Bertagna, X.; Favrod-Coune, C.; Escourolle, H.; Beuzeboc, P.; Christoforov, B.; Girard, F.; Luton, J.P. 1989: Suppression of ectopic adrenocorticotropin secretion by the long-acting somatostatin analog octreotide. Journal of Clinical Endocrinology and Metabolism 68(5): 988-991
Itoh, M.; Mukasa, A.; Tokunaga, Y.; Hiramine, C.; Hojo, K. 1992: Suppression of efferent limb of testicular autoimmune response by a regulatory CD4+ T cell line in mice. Clinical and Experimental Immunology 87(3): 455-460
Yoshimura, M.; Hachiya, T.; Ochi, Y.; Nagasaka, A.; Takeda, A. 1977: Suppression of elevated serum TSH levels in hypothyroidism by fusaric acid. Journal of Clinical Endocrinology and Metabolism 45(1): 95-98
Talley, N.J.; Ellard, K.; Jones, M.; Tennant, C.; Piper, D.W. 1988: Suppression of emotions in essential dyspepsia and chronic duodenal ulcer. a case-control study. Scandinavian Journal of Gastroenterology 23(3): 337-340
Trevor, K.; Linney, E.; Oshima, R.G. 1987: Suppression of endo B cytokeratin by its antisense RNA inhibits the normal coexpression of endo a cytokeratin. Proceedings of the National Academy of Sciences of the United States of America 84(4): 1040-1044
Jougasaki, M.; Kugiyama, K.; Saito, Y.; Nakao, K.; Imura, H.; Yasue, H. 1992: Suppression of endothelin-1 secretion by lysophosphatidylcholine in oxidized low density lipoprotein in cultured vascular endothelial cells. Circulation Research 71(3): 614-619
Suzuki, S.; Nakano, K. 1985: Suppression of endotoxin-induced corticosterone secretion in rats by H1-antihistamine. American Journal of Physiology 248(1 Part 1): E26-E30
Walter, J.F.; Stoughton, R.B.; DeQuoy, P.R. 1978: Suppression of epidermal proliferation by ultraviolet light, coal tar and anthralin. British Journal of Dermatology 99(1): 89-96
Aicardi, G.; Schwartzkroin, P.A. 1990: Suppression of epileptiform burst discharges in CA3 neurons of rat hippocampal slices by the organic calcium channel blocker, verapamil. Experimental Brain Research 81(2): 288-296
Hoffman, R.; Zanjani, E.D.; Lutton, J.D.; Zalusky, R.; Wasserman, L.R. 1977: Suppression of erythroid-colony formation by lymphocytes from patients with aplastic anemia. New England Journal of Medicine 296(1): 10-13
Davidson, J.N.; Bogorad, L. 1977: Suppression of erythromycin resistance in ery-M1 mutants of Chlamydomonas reinhardi. Molecular and General Genetics: Mgg 157(1): 39-46
Morioka, K.; Tanaka, K. 1988: Suppression of erythropoiesis by factor(s) released from bone marrow cells or pokeweed mitogen-stimulated spleen cells of Syrian hamster. Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 51(6): 975-984
McAllister, R.G.; Markesbery, W.R.; Ware, R.W.; Howell, S.M. 1977: Suppression of essential tremor by propranolol: correlation of effect with drug plasma levels and intensity of beta-adrenergic blockade. Annals of Neurology 1(2): 160-166
McAllister, R.G.; Markesbery, W.R.; Ware, R.W.; Howell, S.M. 1976: Suppression of essential tremor by propranolol: correlation of effect with intensity of beta-adrenergic blockade. Transactions of the American Neurological Association 101: 267-269
Wetterwald, A.; Toffler, O.; de Weck, A.L.; Blaser, K. 1986: Suppression of established IgE antibody responses with isologous anti-idiotypic antibodies in guinea pigs. Molecular Immunology 23(3): 347-356
Shiomi, M.; Ito, T.; Watanabe, Y.; Tsujita, Y.; Kuroda, M.; Arai, M.; Fukami, M.; Fukushige, J.; Tamura, A. 1990: Suppression of established atherosclerosis and xanthomas in mature WHHL rabbits by keeping their serum cholesterol levels extremely low. Effect of pravastatin sodium in combination with cholestyramine. Atherosclerosis 83(1): 69-80
Hearing, V.J.; Leong, S.P.; Vieira, W.D.; Law, L.W. 1991: Suppression of established pulmonary metastases by murine melanoma-specific monoclonal antibodies. International Journal of Cancer 47(1): 148-153
Gierthy, J.F.; Lincoln, D.W.; Gillespie, M.B.; Seeger, J.I.; Martinez, H.L.; Dickerman, H.W.; Kumar, S.A. 1987: Suppression of estrogen-regulated extracellular tissue plasminogen activator activity of MCF-7 cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Cancer Research 47(23): 6198-6203
Amit, Z.; Levitan, D.E.; Lindros, K.O. 1976: Suppression of ethanol intake following administration of dopamine-beta-hydroxylase inhibitors in rats. Archives Internationales de Pharmacodynamie et de Therapie 223(1): 114-119
Colombo, G.; Mosca, E.; Gessa, G.L.; Fadda, F. 1990: Suppression of ethanol intake in ethanol-preferring rats by 1,4-butanediol. Alcohol 7(6): 503-505
Trzaskowska, E.; Puciłowski, O.; Dyr, W.; Kostowski, W.; Hauptmann, M. 1986: Suppression of ethanol tolerance and dependence in rats treated with DSP-4, a noradrenergic neurotoxin. Drug and Alcohol Dependence 18(4): 349-353
King, D.C.; Hirst, M. 1990: Suppression of ethanol-induced cardiac hypertrophy by beta-adrenoceptor blockade. Journal of Molecular and Cellular Cardiology 22(5): 523-531
Poling, A.; Thompson, T. 1977: Suppression of ethanol-reinforced lever pressing by delaying food availability. Journal of the Experimental Analysis of Behavior 28(3): 271-283
Naito, M.; Kudo, I.; Nakagawa, Y.; Waku, K.; Nojiri, H.; Saito, M.; Inoue, K. 1991: Suppression of ethanolamine-containing glycerophospholipid synthesis in HL-60 cells during retinoic acid-induced differentiation. Journal of Biochemistry 110(4): 469-471
Abe, T.; Tsuiki, T.; Ito, S.; Endo, Y.; Suzuki, K.; O-Uchi, T. 1990: Suppression of evoked otoacoustic emissions by contralateral noise exposure in humans. Nihon Jibiinkoka Gakkai Kaiho 93(11): 1890-1897
Knight, H. 1989: Suppression of exercise-induced angina by magnesium sulfate in patients with variant angina. Journal of the American College of Cardiology 13(4): 956
Godfrey, S.; König, P. 1975: Suppression of exercise-induced asthma by salbutamol, theophylline, atropine, cromolyn, and placebo in a group of asthmatic children. Pediatrics 56(5 Pt-2(Suppl): 930-934
Yano, K.; Miyauchi, K.; Mitsuoka, T.; Hashiba, K. 1990: Suppression of exercise-induced ventricular arrhythmias by propranolol and diltiazem in a woman without organic heart disease--a case report. Angiology 41(1): 70-75
Klempnauer, J.; Lück, R.; Brüsch, U.; Steiniger, B. 1990: Suppression of exocrine secretion does not lead to disruption of endocrine function of pancreas transplants. Langenbecks Archiv für Chirurgie 375(4): 193-199
Yamamura, T.; Da-Lin, Y.; Satoh, J.; Tabira, T. 1987: Suppression of experimental allergic encephalomyelitis by 15-deoxyspergualin. Journal of the Neurological Sciences 82(1-3): 101-110
Levine, S.; Sowinski, R. 1978: Suppression of experimental allergic encephalomyelitis by 6-hydroxyphthalaldehydic acid, O-(p-chlorobenzyl)oxime (EN3638). Journal of Immunology 120(2): 602-606
Arnon, R.; Teitelbaum, D.; Sela, M. 1989: Suppression of experimental allergic encephalomyelitis by COP1--relevance to multiple sclerosis. Israel Journal of Medical Sciences 25(12): 686-689
Levine, S.; Sowinski, R. 1979: Suppression of experimental allergic encephalomyelitis by EN3638: dependence on adjuvants and treatment schedules. Journal of Immunopharmacology 1(4): 547-557
Strejan, G.H.; St Louis, J. 1990: Suppression of experimental allergic encephalomyelitis by MBP-coupled lymphoid cells and by MBP-liposomes: a comparison. Cellular Immunology 127(2): 284-298
Hunter, N.; Weston, K.M.; Bowern, N.A. 1991: Suppression of experimental allergic encephalomyelitis by alpha 2-macroglobulin. Immunology 73(1): 58-63
Voorthuis, J.A.; Uitdehaag, B.M.; De Groot, C.J.; Goede, P.H.; van der Meide, P.H.; Dijkstra, C.D. 1990: Suppression of experimental allergic encephalomyelitis by intraventricular administration of interferon-gamma in Lewis rats. Clinical and Experimental Immunology 81(2): 183-188
Nemoto, K.; Abe, F.; Takita, T.; Nakamura, T.; Takeuchi, T.; Umezawa, H. 1987: Suppression of experimental allergic encephalomyelitis in guinea pigs by spergualin and 15-deoxyspergualin. Journal of Antibiotics 40(8): 1193-1194
Webb, C.; Teitelbaum, D.; Abramsky, O.; Arnon, R.; Sela, M. 1975: Suppression of experimental allergic encephalomyelitis in rhesus monkeys by a synthetic basic copolymer. Israel Journal of Medical Sciences 11(12): 1388
Lider, O.; Baharav, E.; Mekori, Y.A.; Miller, T.; Naparstek, Y.; Vlodavsky, I.; Cohen, I.R. 1989: Suppression of experimental autoimmune diseases and prolongation of allograft survival by treatment of animals with low doses of heparins. Journal of Clinical Investigation 83(3): 752-756
Prosiegel, M.; Neu, I.; Ruhenstroth-Bauer, G.; Hoffmann, G.; Vogl, S.; Mehlber, L.; Wildfeuer, A. 1989: Suppression of experimental autoimmune encephalomyelitis by sulfasalazine. New England Journal of Medicine 321(8): 545-546
Prosiegel, M.; Neu, I.; Mallinger, J.; Wildfeuer, A.; Mehlber, L.; Vogl, S.; Hoffmann, G.; Ruhenstroth-Bauer, G. 1989: Suppression of experimental autoimmune encephalomyelitis by dual cyclo-oxygenase and 5-lipoxygenase inhibition. Acta Neurologica Scandinavica 79(3): 223-226
Lider, O.; Santos, L.M.; Lee, C.S.; Higgins, P.J.; Weiner, H.L. 1989: Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. II. Suppression of disease and in vitro immune responses is mediated by antigen-specific CD8+ T lymphocytes. Journal of Immunology 142(3): 748-752
Miller, A.; Lider, O.; al-Sabbagh, A.; Weiner, H.L. 1992: Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. V. Hierarchy of suppression by myelin basic protein from different species. Journal of Neuroimmunology 39(3): 243-250
Braley-Mullen, H.; Sharp, G.C.; Kyriakos, M.; Hayes, N.; Dunn, C.; Jepsen, P.; Sanders, R.D. 1978: Suppression of experimental autoimmune thyroiditis in the guinea pig by pretreatment with thyroglobulin in incomplete Freund's adjuvant. Cellular Immunology 39(2): 289-296
Mahlberg, K.; Uusitalo, H.; Uusitalo, R.; Palkama, A.; Tallberg, T. 1987: Suppression of experimental autoimmune uveitis in guinea pigs by ethylenediamine tetra-acetic acid, corticosteroids, and cyclosporin. Journal of Ocular Pharmacology 3(3): 199-210
Mahlberg, K.; Uusitalo, R.; Uusitalo, H.; Palkama, A.; Tallberg, T. 1987: Suppression of experimental autoimmune uveitis in guinea-pigs by inhibition of phospholipase A2. Acta Ophthalmologica. Suppl 182: 166-168
Hara, Y.; Caspi, R.R.; Wiggert, B.; Chan, C.C.; Wilbanks, G.A.; Streilein, J.W. 1992: Suppression of experimental autoimmune uveitis in mice by induction of anterior chamber-associated immune deviation with interphotoreceptor retinoid-binding protein. Journal of Immunology 148(6): 1685-1692
Singh, V.K.; Kalra, H.K.; Yamaki, K.; Shinohara, T. 1992: Suppression of experimental autoimmune uveitis in rats by the oral administration of the uveitopathogenic S-antigen fragment or a cross-reactive homologous peptide. Cellular Immunology 139(1): 81-90
Peng, B.; Yoshitoshi, T.; Shichi, H. 1992: Suppression of experimental autoimmune uveoretinitis by intraorchidic administration of S-antigen. Autoimmunity 14(2): 149-153
Ruiz-Moreno, J.M.; Misiuk-Hojlo, M.; Thillaye, B.; de Kozak, Y. 1992: Suppression of experimental autoimmune uveoretinitis by prazosin, an alpha 1-adrenergic receptor antagonist. Current Eye Research 11 Suppl: 135-140
Peichev, L. 1992: Suppression of experimental barbiturate and phenytoin withdrawal syndrome using valproate sodium. Folia Medica 34(3-4): 3-7
Sugimoto, Y.; Watanabe, M.; Oh-hara, T.; Sato, S.; Isoe, T.; Tsuruo, T. 1991: Suppression of experimental lung colonization of a metastatic variant of murine colon adenocarcinoma 26 by a monoclonal antibody 8F11 inhibiting tumor cell-induced platelet aggregation. Cancer Research 51(3): 921-925
Meredith, T.A.; Ficker, L.; Stevens, R.; Olkowski, Z.; Anderson, M.; Hartmann, J.; Crocker, I. 1988: Suppression of experimental tractional retinal detachment by low-dose radiation therapy. Archives of Ophthalmology 106(5): 673-675
Klinenberg, J.R.; Bluestone, R.; Waisman, J. 1977: Suppression of experimental urate nephropathy by salicylate. Advances in Experimental Medicine and Biology 76b: 176-178
Rao, N.A.; Atalla, L.; Linker-Israeli, M.; Chen, F.Y.; George, F.W.; Martin, W.J.; Steinman, L. 1989: Suppression of experimental uveitis in rats by anti-I-A antibodies. Investigative Ophthalmology and Visual Science 30(11): 2348-2355
Ahlenius, S.; Hillegaart, V.; Thorell, G.; Magnusson, O.; Fowler, C.J. 1987: Suppression of exploratory locomotor activity and increase in dopamine turnover following the local application of cis-flupenthixol into limbic projection areas of the rat striatum. Brain Research 402(1): 131-138
Weislow, O.S.; Wheelock, E.F. 1975: Suppression of extablished Friend virus leukemia by statolon: potentiation of statolon's leukemosuppressive activity by chlorite-oxidized oxyamylose. Infection and Immunity 11(1): 129-136
Zenz, W.; Muntean, W. 1987: Suppression of factor VIIi inhibitor in children with hemophilia a. Padiatrie und Padologie 22(4): 345-352
Wellman, M.L.; Kociba, G.J.; Mathes, L.E.; Olsen, R.G. 1988: Suppression of feline bone marrow fibroblast colony-forming units by feline leukemia virus. American Journal of Veterinary Research 49(2): 227-230
Egberink, H.; Borst, M.; Niphuis, H.; Balzarini, J.; Neu, H.; Schellekens, H.; De Clercq, E.; Horzinek, M.; Koolen, M. 1990: Suppression of feline immunodeficiency virus infection in vivo by 9-(2-phosphonomethoxyethyl)adenine. Proceedings of the National Academy of Sciences of the United States of America 87(8): 3087-3091
Metzger, Z.; Hoffeld, J.T.; Oppenheim, J.J. 1986: Suppression of fibroblast proliferation by activated macrophages: involvement of H2O2 and a non-prostaglandin e product of the cyclooxygenase pathway. Cellular Immunology 100(2): 501-514
Hanley, C.A.; Elias, R.M.; Movat, H.Z.; Johnston, M.G. 1989: Suppression of fluid pumping in isolated bovine mesenteric lymphatics by interleukin-1: interaction with prostaglandin E2. Microvascular Research 37(2): 218-229
Bronskill, P.M.; Wong, J.T. 1988: Suppression of fluorescence of tryptophan residues in proteins by replacement with 4-fluorotryptophan. Biochemical Journal 249(1): 305-308
Skrinska, V.A.; Konieczkowski, M.; Gerrity, R.G.; Galang, C.F.; Rebec, M.V. 1988: Suppression of foam cell lesions in hypercholesterolemic rabbits by inhibition of thromboxane A2 synthesis. Arteriosclerosis 8(4): 359-367
Yoshikura, H. 1989: Suppression of focus formation by bovine papillomavirus-transformed cells by contact with non-transformed cells: involvement of sugar(s) and phosphorylation. International Journal of Cancer 44(5): 885-891
Weiss, T.J.; Armstrong, D.T. 1979: Suppression of follicular cAMP and steroid response to gonadotrophins by pretreatment with gonadotrophin. Molecular and Cellular Endocrinology 13(3): 229-239
Fraser, H.M.; Sandow, J. 1985: Suppression of follicular maturation by infusion of a luteinizing hormone-releasing hormone agonist starting during the late luteal phase in the stumptailed macaque monkey. Journal of Clinical Endocrinology and Metabolism 60(3): 579-584
Boer, D.P.; Epling, W.F.; Pierce, W.D.; Russell, J.C. 1990: Suppression of food deprivation-induced high-rate wheel running in rats. Physiology and Behavior 48(2): 339-342
McCarthy, D.O.; Kluger, M.J.; Vander, A.J. 1985: Suppression of food intake during infection: is interleukin-1 involved?. American Journal of Clinical Nutrition 42(6): 1179-1182
Tabara, M.; Watanabe, M. 1988: Suppression of footpad reaction in mice by 12-tetradecanoylphorbol 13-acetate and 7,12-dimethylbenz[a]anthracene. Japanese Journal of Experimental Medicine 58(2): 67-72
Tone, T.; Eto, H.; Katsuoka, K.; Nishioka, K.; Nishiyama, S. 1991: Suppression of gamma-interferon induced HLA-DR antigen expression on normal and transformed keratinocytes by 1,25 (OH)2 vitamin D3. Nihon Hifuka Gakkai Zasshi. Japanese Journal of Dermatology 101(5): 519-525
Gonzalez, H.; Ahmed, T. 1986: Suppression of gastric H2-receptor mediated function in patients with bronchial asthma and ragweed allergy. Chest 89(4): 491-496
Festen, H.P.; Lamers, C.B.; van Tongeren, J.H. 1978: Suppression of gastric acid production using cimetidine; results of a double-blind study of the significance of cimetidine for the treatment of peptic ulcers. Nederlands Tijdschrift Voor Geneeskunde 122(24): 862-865
Villar, H.V.; Watayou, T.; Booth, R.A.; Rayford, P.L.; Reeder, D.D.; Thompson, J.C. 1976: Suppression of gastric secretion and serum gastrin by gastrin antibody. American Journal of Surgery 131(1): 64-68
Mimura, T.; Tsujikawa, K.; Yasuda, N.; Nakajima, H.; Haruyama, M.; Ohmura, T.; Okabe, M. 1988: Suppression of gastric ulcer induced by stress and HCL-ethanol by intravenously administered metallothionein-Ii. Biochemical and Biophysical Research Communications 151(2): 725-729
Shah, D.B.; DeLorenzo, L. 1977: Suppression of gene 49 mutations of bacteriophage T4 by a second mutation in gene X: structure of pseudorevertant DNA. Journal of Virology 24(3): 794-804
Bourque, J.E.; Folk, W.R. 1992: Suppression of gene expression in plant cells utilizing antisense sequences transcribed by RNA polymerase IIi. Plant Molecular Biology 19(4): 641-647
Bursuker, I.; North, R.J. 1985: Suppression of generation of concomitant antitumor immunity by passively transferred suppressor T cells from tumor-bearing donors. Cancer Immunology Immunotherapy: Cii 19(3): 215-218
Mawas, C.; Charmot, D.; Comoy, A.; Sasportes, M. 1977: Suppression of generation of human cytotoxic effectors by lectins or lectin-activated peripheral blood lymphocytes. European Journal of Immunology 7(1): 11-15
Hayatsu, H.; Inada, N.; Kakutani, T.; Arimoto, S.; Negishi, T.; Mori, K.; Okuda, T.; Sakata, I. 1992: Suppression of genotoxicity of carcinogens by (-)-epigallocatechin gallate. Preventive Medicine 21(3): 370-376
Kawaguchi, S.; Tanaka, H.; Hoshino, K.; Katsumata, Y.; Masuda, Y.; Ishizaki, M.; Yamanaka, N.; Masugi, Y. 1988: Suppression of glomerular IgA deposition in ddY mice through periodic injections of lipopolysaccharides. Clinical Immunology and Immunopathology 48(3): 362-370
Li, N.Q.; Tu, C.P. 1986: Suppression of glutathione S-transferases in rat seminal vesicles or pituitary glands. Biochemical and Biophysical Research Communications 136(3): 1057-1062
Mizushima, Y. 1979: Suppression of glycogen storage with betamethasone 17,21-dipropionate in fetal rat liver--II. Inhibition of glycogenic action of cortisol and insulin in the liver in organ culture. Biochemical Pharmacology 28(6): 741-745
Coy, D.H.; Coy, E.J.; Vilchez-Martinez, J.A.; de la Cruz, A.; Arimura, A.; Schally, A.V. 1976: Suppression of gonadotropin release and ovulation in animals by inhibitory analogs of luteinizing hormone-releasing hormone. Current Topics in Molecular Endocrinology 3: 339-354
Kappy, M.; Stuart, T.; Perelman, A.; Clemons, R. 1989: Suppression of gonadotropin secretion by a long-acting gonadotropin-releasing hormone analog (leuprolide acetate, Lupron Depot) in children with precocious puberty. Journal of Clinical Endocrinology and Metabolism 69(5): 1087-1089
Süsal, C.; Terness, P.; Opelz, G. 1987: Suppression of graft-versus-host reaction in rats by pretreatment of donor cells with a non-cytotoxic immunosuppressive serum. Transplantation Proceedings 19(1 Pt 1): 572-575
Vaidya, S.; Mamlok, R.; Daeschner, C.W.; Williams, J.; Ruth, J.; Goldblum, R.M. 1991: Suppression of graft-versus-host reaction in severe combined immunodeficiency with maternal-fetal T cell engraftment. American Journal of Pediatric Hematology/Oncology 13(2): 172-175
Knulst, A.C.; Bril-Bazuin, C.; Savelkoul, H.F.; Benner, R. 1991: Suppression of graft-versus-host reactivity by a single host-specific blood transfusion to prospective donors of hemopoietic cells. Transplantation 52(3): 534-539
Morison, W.L.; Pike, R.A. 1985: Suppression of graft-versus-host reactivity in the mouse popliteal node by UVB radiation. Journal of Investigative Dermatology 84(6): 483-486
Hutchinson, R.J.; Bunnell, K.; Thoene, J.G. 1985: Suppression of granulopoietic progenitor cell proliferation by metabolites of the branched-chain amino acids. Journal of Pediatrics 106(1): 62-65
Lee, C.A.; Beckwith, J. 1986: Suppression of growth and protein secretion defects in Escherichia coli secA mutants by decreasing protein synthesis. Journal of Bacteriology 166(3): 878-883
Cocks, B.G.; Vairo, G.; Bodrug, S.E.; Hamilton, J.A. 1992: Suppression of growth factor-induced CYL1 cyclin gene expression by antiproliferative agents. Journal of Biological Chemistry 267(17): 12307-12310
Plewe, G.; Noelken, G.; Krause, U.; Beyer, J.; del Pozo, E. 1987: Suppression of growth hormone and somatomedin C by long-acting somatostatin analog SMS 201-995 in type i diabetes mellitus. Hormone Research 27(1): 7-12
Chow, S.C.; Sisfontes, L.; Björkhem, I.; Jondal, M. 1989: Suppression of growth in a leukemic T cell line by n-3 and n-6 polyunsaturated fatty acids. Lipids 24(8): 700-704
Hill, R.W.; Welsch, C.W. 1988: Suppression of growth of 7,12-dimethylbenzanthracene-induced mammary carcinomas in female rats by repeated whole-body hyperthermia (41-42 degrees C). International Journal of Radiation Oncology Biology Physics 14(2): 337-345
Beck, J.S.; Potts, R.C.; Brown, R.A.; Deraedt, R. 1987: Suppression of growth of PHA-stimulated human lymphocytes by a novel steroid (RU 28 362) lacking the 21-OH group. International Journal of Immunopharmacology 9(8): 861-867
Minden, P.; Brunda, M.J.; Ferguson, H.R. 1978: Suppression of growth of guinea pig line-10 hepatocarcinoma. II. Effect of passive transfer of xenogeneic and syngeneic antibodies and normal lymphoid cells. Journal of Immunology 121(5): 1933-1938
Chelmicka-Schorr, E.; Arnason, B.G. 1979: Suppression of growth of mouse neuroblastoma and A-10 adenocarcinoma in newborn mice treated with the ganglionic blocking agent chlorisondamine. European Journal of Cancer 15(4): 533-535
Matsunami, K.; Imai, A.; Ohno, T.; Tamaya, T. 1991: Suppression of growth-promoting activity in extract from human uterine cancer by cyclic AMP-mediated mechanism. Research Communications in Chemical Pathology and Pharmacology 73(3): 371-374
McFarlain, R.A.; Andy, O.J.; Scott, R.W.; Wheatley, M.L. 1975: Suppression of headbanging on the ward. Psychological Reports 36(1): 315-321
Fukushima, H.; Tsubokura, M.; Otsuki, K.; Kawaoka, Y. 1986: Suppression of heat-stable enterotoxin production by Yersinia spp. in milk. Veterinary Microbiology 11(1-2): 163-172
Iishi, Y.; Kosaka, M.; Mizuguchi, T.; Toyota, K.; Takaue, Y.; Kawano, Y.; Saito, S. 1991: Suppression of hematopoiesis by activated T-cells in infectious mononucleosis associated with pancytopenia. International Journal of Hematology 54(1): 65-73
Wu, T.J.; Luu, K.C.; Lin, S.Y.; Hwang, C.L.; Wang, K.C.; Huang, H.H.; Yu, H.L.; Chung, J.D.; Huang, F.Y.; Chao, C.C. 1990: Suppression of hemodynamic change before extubation--lidocaine through modified endotracheal tube. Ma Zui Xue Za Zhi 28(2): 121-126
Bartsokas, S.K.; Trichopoulou-Polychronopoulou, A.D.; Charissiadou, A.; Valsamakis, S.; Kalaitjidou, C. 1975: Suppression of heparine-induced increment of rat free fatty acids by oxprenolol. Arzneimittel-Forschung 25(5): 774-775
Friedman, M.A.; Couch, D.B. 1976: Suppression of hepatic DMN demethylase activity by nitrososarcosine and other nitrosamines. Biochemical Pharmacology 25(24): 2709-2712
Fujino, Y.; Nakayama, K.; Yoshimura, K.; Furuya, Y.; Yonaga, T. 1988: Suppression of hepatic HMG-CoA reductase activity by beta-muricholic acid in mice fed a diet containing cholesterol and cholic acid. Japanese Journal of Pharmacology 46(4): 421-423
Yamaguchi, Y.; Mori, K.; Bollinger, R.R. 1990: Suppression of hepatic allograft rejection in the rat by mitomycin C-treated donor splenocytes: analysis of the immune status. Journal of Clinical and Laboratory Immunology 32(2): 59-66
Holness, M.J.; Palmer, T.N.; Sugden, M.C. 1988: Suppression of hepatic glucose output after glucose re-feeding in the gsd/gsd rat. Biochemical Journal 252(3): 928-929
Turner, A.R.; Gummerman, L.W.; Boggs, D.R. 1985: Suppression of hepatic hematopoiesis with radioactive gold (198Au). Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 26(4): 366-367
Yamazoe, Y.; Murayama, N.; Shimada, M.; Imaoka, S.; Funae, Y.; Kato, R. 1989: Suppression of hepatic levels of an ethanol-inducible P-450DM/j by growth hormone: relationship between the increased level of P-450DM/j and depletion of growth hormone in diabetes. Molecular Pharmacology 36(5): 716-722
Tzung, S.P.; Gaines, K.C.; Lance, P.; Ehrke, M.J.; Cohen, S.A. 1990: Suppression of hepatic lymphokine-activated killer cell induction by murine Kupffer cells and hepatocytes. Hepatology 12(4 Part 1): 644-652
Duitsman, P.K.; Chen, H.W.; Cook, L.R.; Hendrich, S. 1992: Suppression of hepatic prostaglandin F2 alpha in rats by dietary alpha-tocopherol acetate is independent of total hepatic alpha-tocopherol. Prostaglandins Leukotrienes and Essential Fatty Acids 47(1): 63-68
Kanai, K.; Iwata, K.; Nakao, K.; Kako, M.; Okamoto, H. 1990: Suppression of hepatitis C virus RNA by interferon-alpha. Lancet 336(8709): 245
Nsiah, Y.A.; Tolman, R.L.; Karkas, J.D.; Rapp, F. 1990: Suppression of herpes simplex virus type 1 reactivation from latency by (+-)-9-([(Z)-2-(hydroxymethyl)cyclohexyl]methyl) guanine (L-653,180) in vitro. Antimicrobial Agents and ChemoTherapy 34(8): 1551-1555
Elliott, L.H.; Brooks, W.H.; Roszman, T.L. 1992: Suppression of high affinity IL-2 receptors on mitogen activated lymphocytes by glioma-derived suppressor factor. Journal of Neuro-Oncology 14(1): 1-7
Clark, A.G.; Carrol, N. 1986: Suppression of high-affinity ligand binding to the major glutathione S-transferase from Galleria mellonella by physiological concentrations of glutathione. Biochemical Journal 233(2): 325-331
Leonard, B.J.; McNaughton, B.L.; Barnes, C.A. 1987: Suppression of hippocampal synaptic plasticity during slow-wave sleep. Brain Research 425(1): 174-177
Rhoades, R.B.; Leifer, K.N.; Cohan, R.; Wittig, H.J. 1975: Suppression of histamine-induced pruritus by three antihistaminic drugs. Journal of Allergy and Clinical Immunology 55(3): 180-185
Kontou-Fili, K.; Paleologos, G.; Herakleous, M. 1989: Suppression of histamine-induced skin reactions by loratadine and cetirizine diHCl. European Journal of Clinical Pharmacology 36(6): 617-619
Roman, I.J.; Kassem, N.; Gural, R.P.; Herron, J. 1986: Suppression of histamine-induced wheal response by loratadine (SCH 29851) over 28 days in man. Annals of Allergy 57(4): 253-256
London, F.S.; Brinker, J.M.; Ziaie, Z.; Kefalides, N.A. 1990: Suppression of host mRNA in human smooth muscle cells by a virion competent factor in herpes simplex virus type 1. Laboratory Investigation; a Journal of Technical Methods and Pathology 62(2): 189-195
Nakane, A.; Numata, A.; Minagawa, T. 1990: Suppression of host resistance against Listeria monocytogenes infection by 15-deoxyspergualin in mice. Immunology 71(4): 560-565
Roughneen, P.T.; Kulkarni, A.D.; Gouma, D.J.; Fanslow, W.C.; Rowlands, B.J. 1986: Suppression of host-versus-graft response in experimental biliary obstruction. Transplantation 42(6): 687-689
Zhu, L.P.; Yang, L.M.; Zhang, S.Z.; Fang, F. 1987: Suppression of human B cell proliferation by PGE. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae 9(5): 390-393
Zhu, L.P.; Fang, F.; Yang, L.M.; Chen, D.; Jiang, M.; Zhang, S.Z.; Song, Q.F.; Zeng, X.F.; Ding, Y.M.; Liu, S.L. 1986: Suppression of human B cell proliferation by prostaglandin e. Proceedings of the Chinese Academy of Medical Sciences and the Peking Union Medical College 1(4): 239-246
Morgan, E.L.; McClurg, M.R.; Janda, J.A. 1990: Suppression of human B lymphocyte activation by beta-endorphin. Journal of Neuroimmunology 28(3): 209-217
Weimer, R.; Terness, P.; Opelz, G. 1987: Suppression of human B- and T-lymphocyte response in vitro with serum from rabbits immunized with antibody-coated autologous or allogeneic cells. Transplantation Proceedings 19(5): 4289-4293
Samson, L.; Derfler, B.; Waldstein, E.A. 1986: Suppression of human DNA alkylation-repair defects by Escherichia coli DNA-repair genes. Proceedings of the National Academy of Sciences of the United States of America 83(15): 5607-5610
Millet, I.; Revillard, J.P. 1988: Suppression of human IgA-B-cell maturation by IgA-binding factors requires T cells. International Archives of Allergy and Applied Immunology 87(4): 367-370
D'Amore, P.J.; Golub, S.H. 1985: Suppression of human NK cell cytotoxicity by an MLC-Generated cell population. Journal of Immunology 134(1): 272-279
Van Epps, D.E.; Reed, K.; Williams, R.C. 1978: Suppression of human PMN bactericidal activity by human IgA paraproteins. Cellular Immunology 36(2): 363-376
Goodwin, J.S.; Bankhurst, A.D.; Messner, R.P. 1977: Suppression of human T-cell mitogenesis by prostaglandin. Existence of a prostaglandin-producing suppressor cell. Journal of Experimental Medicine 146(6): 1719-1734
Tsukada, Y.; Ohkawa, K.; Hibi, N. 1985: Suppression of human alpha-foetoprotein-producing hepatocellular carcinoma growth in nude mice by an anti alpha-foetoprotein antibody-daunorubicin conjugate with a poly-L-glutamic acid derivative as intermediate drug carrier. British Journal of Cancer 52(1): 111-116
Rolfe, M.W.; Kunkel, S.L.; Rowens, B.; Standiford, T.J.; Cragoe, E.J.; Strieter, R.M. 1992: Suppression of human alveolar macrophage-derived cytokines by amiloride. American Journal of Respiratory Cell and Molecular Biology 6(6): 576-582
Baker, S.J.; Markowitz, S.; Fearon, E.R.; Willson, J.K.; Vogelstein, B. 1990: Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249(4971): 912-915
Rosenberg, J.C.; Lysz, K. 1978: Suppression of human cytotoxic lymphocytes by methylprednisolone. An immunosuppressive mechanism of action of steroids. Transplantation 25(3): 115-120
Matsubara, T.; Hirohata, K. 1988: Suppression of human fibroblast proliferation by D-penicillamine and copper sulfate in vitro. Arthritis and Rheumatism 31(8): 964-972
Dickinson, A.M.; Jacobs, E.A.; Williamson, I.K.; Reid, M.M.; Proctor, S.J. 1988: Suppression of human granulocyte-macrophage colony formation in vitro by natural killer cells. Clinical Immunology and Immunopathology 49(1): 83-90
Koibuchi, N.; Kato, M.; Kakegawa, T.; Suzuki, M. 1988: Suppression of human growth hormone (GH)-releasing hormone-induced GH secretion in pentobarbital-anesthetized rats after electrical stimulation of the midbrain central gray and several raphe nuclei. Endocrinology 122(2): 659-664
Kalebic, T.; Kinter, A.; Poli, G.; Anderson, M.E.; Meister, A.; Fauci, A.S. 1991: Suppression of human immunodeficiency virus expression in chronically infected monocytic cells by glutathione, glutathione ester, and N-acetylcysteine. Proceedings of the National Academy of Sciences of the United States of America 88(3): 986-990
Tochikura, T.S.; Nakashima, H.; Kaneko, Y.; Kobayashi, N.; Yamamoto, N. 1987: Suppression of human immunodeficiency virus replication by 3'-azido-3'-deoxythymidine in various human hematopoietic cell lines in vitro: augmentation of the effect by lentinan. Japanese Journal of Cancer Research: Gann 78(6): 583-589
Castro, B.A.; Walker, C.M.; Eichberg, J.W.; Levy, J.A. 1991: Suppression of human immunodeficiency virus replication by CD8+ cells from infected and uninfected chimpanzees. Cellular Immunology 132(1): 246-255
Bosse, D.; Ades, E. 1991: Suppression of human immunoglobulin synthesis by interleukin-4 in tandem with interleukin-2 through large granular lymphocytes. Pathobiology: Journal of Immunopathology Molecular and Cellular Biology 59(6): 391-395
Havell, E.A.; Vilcek, J.; Falcoff, E.; Berman, B. 1975: Suppression of human interferon production by inhibitors of glycosylation. Virology 63(2): 475-483
Haraguchi, S.; Liu, W.T.; Cianciolo, G.J.; Good, R.A.; Day, N.K. 1992: Suppression of human interferon-gamma production by a 17 amino acid peptide homologous to the transmembrane envelope protein of retroviruses: evidence for a primary role played by monocytes. Cellular Immunology 141(2): 388-397
Scuderi, P. 1989: Suppression of human leukocyte tumor necrosis factor secretion by the serine protease inhibitor p-toluenesulfonyl-L-arginine methyl ester (TAME). Journal of Immunology 143(1): 168-173
Van Epps, D.E.; Potter, J.; Vachula, M.; Smith, C.W.; Anderson, D.C. 1989: Suppression of human lymphocyte chemotaxis and transendothelial migration by anti-LFA-1 antibody. Journal of Immunology 143(10): 3207-3210
Denner, J.; Wunderlich, V.; Bierwolf, D. 1986: Suppression of human lymphocyte mitogen response by proteins of the type-D retrovirus PMFV. International Journal of Cancer 37(2): 311-316
Denner, J.; Indzhiia, L.; Wunderlich, V.; Sydow, G.; Bierwolf, D.; Lapin, B.A. 1985: Suppression of human lymphocyte mitogen response by retroviruses of type D. II. Non-activity of Mason-Pfizer monkey virus versus activity of human cell line derived virus PMFV. Archives of Virology 86(3-4): 187-196
Zoschke, D.C.; Staite, N.D. 1987: Suppression of human lymphocyte proliferation by activated neutrophils or H2O2: surviving cells have an altered T helper/T suppressor ratio and an increased resistance to secondary oxidant exposure. Clinical Immunology and Immunopathology 42(2): 160-170
Kleiman, K.S.; Zoschke, D.C. 1985: Suppression of human lymphocyte responses in chronic renal failure mediated by adherent cells: analysis in serum-free media. Journal of Laboratory and Clinical Medicine 106(3): 262-268
Elkhalifa, M.Y.; Ghalib, H.W.; Dafa'Alla, T.; Williams, J.F. 1991: Suppression of human lymphocyte responses to specific and non-specific stimuli in human onchocerciasis. Clinical and Experimental Immunology 86(3): 433-439
Shenker, B.J.; Matt, W.C. 1987: Suppression of human lymphocyte responsiveness by forskolin: reversal by 12-O-tetradecanoyl phorbol 13-acetate, diacylglycerol and ionomycin. Immunopharmacology 13(1): 73-86
Specter, S.; Lancz, G.; Goodfellow, D. 1991: Suppression of human macrophage function in vitro by delta 9-tetrahydrocannabinol. Journal of Leukocyte Biology 50(5): 423-426
Matsui, M.; Nakanishi, T.; Noguchi, T.; Imai, K.; Yachi, A.; Ferrone, S. 1985: Suppression of human melanoma growth in nude mice injected with anti high-molecular-weight melanoma-associated antigen monoclonal antibody 225.28S conjugated to purothionin. Japanese Journal of Cancer Research: Gann 76(2): 119-123
Wei, S.; Serbousek, D.; McMillen, S.; Blanchard, D.K.; Djeu, J.Y. 1991: Suppression of human monocyte function against Candida albicans by autologous IL-2-induced lymphokine-activated killer cells. Journal of Immunology 146(1): 337-342
Lozzio, B.B.; Machado, E.A.; Lair, S.A.; Lozzio, C.B. 1977: Suppression of human myelosarcoma growth in athymic mice by a primate antiserum. Cancer Treatment Reports 61(9): 1679-1684
Chang, Z.L.; Liu, K.L.; Lao, H.; Dong, Q.G.; Yao, Z. 1986: Suppression of human natural killer (NK) cell activity by differentiated mature macrophages in vitro. Shi Yan Sheng Wu Xue Bao 19(2): 211-225
Baker, D.G.; Krakauer, K.A.; Tate, G.; Laposata, M.; Zurier, R.B. 1989: Suppression of human synovial cell proliferation by dihomo-gamma-linolenic acid. Arthritis and Rheumatism 32(10): 1273-1281
Kaminski, N.E.; Jordan, S.D.; Holsapple, M.P. 1989: Suppression of humoral and cell-mediated immune responses by carbon tetrachloride. Fundamental and Applied Toxicology: Official Journal of the Society of Toxicology 12(1): 117-128
Urso, P.; Gengozian, N.; Rossi, R.M.; Johnson, R.A. 1986: Suppression of humoral and cell-mediated immune responses in vitro by benzo(a)pyrene. Journal of Immunopharmacology 8(2): 223-241
Whisler, R.L.; Stobo, J.D. 1978: Suppression of humoral and delayed hypersensitivity responses by distinct T cell subpopulations. Journal of Immunology 121(2): 539-542
Bokeriia, L.A.; Frolova, M.A.; Kostava, V.T. 1979: Suppression of humoral antibody synthesis on exposure to hyperbaric oxygenation. Biulleten' Eksperimental'noi Biologii i Meditsiny 87(4): 320-322
Metzger, B.; Podlech, J.; Müller, S.; Falke, D. 1988: Suppression of humoral immune response against herpes simplex virus induced by defective strains, ts- and TK- mutants. Archives of Virology 99(3-4): 143-152
Kaminski, N.E.; Jordan, S.D.; Page, D.; Kim, B.S.; Holsapple, M.P. 1989: Suppression of humoral immune responses by dialkylnitrosamines: structure-activity relationships. Fundamental and Applied Toxicology: Official Journal of the Society of Toxicology 12(2): 321-332
Nemoto, K.; Ito, J.; Abe, F.; Nakamura, T.; Takeuchi, T.; Umezawa, H. 1987: Suppression of humoral immunity in dogs by 15-deoxyspergualin. Journal of Antibiotics 40(7): 1065-1066
Komissarenko, S.V.; Zhuravskiĭ, N.I.; Karleva, N.P.; Gulyĭ, M.F. 1977: Suppression of hypersensitivity of the delayed and immediate types in guinea pigs by methylene diphosphonic acid. Biulleten' Eksperimental'noi Biologii i Meditsiny 84(9): 339-341
Magae, J.; Hosokawa, T.; Matsuda, Y.; Hotta, M.; Hayasaki, J.; Nagai, K.; Ando, K.; Yamasaki, M.; Tamura, G. 1987: Suppression of hypertriglyceridemia of Ehrlich carcinoma-bearing mice by an antibiotic, ascofuranone. Cancer Research 47(1): 96-99
Blum, I.; Aderka, D.; Doron, M.; Laron, Z. 1978: Suppression of hypoglycemia by DL-propranolol in malignant insulinoma. New England Journal of Medicine 299(9): 487
Brady, R.J.; Swann, J.W. 1988: Suppression of ictal-like activity by kynurenic acid does not correlate with its efficacy as an NMDA receptor antagonist. Epilepsy Research 2(4): 232-238
Dohi, Y.; Nisonoff, A. 1979: Suppression of idiotype and generation of suppressor T cells with idiotype-conjugated thymocytes. Journal of Experimental Medicine 150(4): 909-918
Moldoveanu-Dumitrescu, R.; Iurascu, C.; Popp, I. 1979: Suppression of immune anti-tumor lymphocytes by macrophages of advanced tumor bearing rats, across a cell impermeable membrane. Neoplasma 26(6): 697-702
Shalaby, M.R.; Ammann, A.J. 1988: Suppression of immune cell function in vitro by recombinant human transforming growth factor-beta. Cellular Immunology 112(2): 343-350
Johnson, K.J.; Anderson, T.P.; Ward, P.A. 1977: Suppression of immune complex-induced inflammation by the chemotactic factor inactivator. Journal of Clinical Investigation 59(5): 951-958
Rapaport, R.; Oleske, J.; Ahdieh, H.; Solomon, S.; Delfaus, C.; Denny, T. 1986: Suppression of immune function in growth hormone-deficient children during treatment with human growth hormone. Journal of Pediatrics 109(3): 434-439
Kramnik, I.B.; Apt, A.S.; Moroz, A.M. 1990: Suppression of immune response by lung cells in experimental tuberculosis. Biulleten' Eksperimental'noi Biologii i Meditsiny 110(7): 77-80
Kato, K. 1988: Suppression of immune response in mice treated with live and killed BCG. Kekkaku: 63(11): 743-755
Pestka, J.J.; Tai, J.H.; Witt, M.F.; Dixon, D.E.; Forsell, J.H. 1987: Suppression of immune response in the B6C3F1 mouse after dietary exposure to the Fusarium mycotoxins deoxynivalenol (vomitoxin) and zearalenone. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 25(4): 297-304
Casebolt, D.B.; Spalding, D.M.; Schoeb, T.R.; Lindsey, J.R. 1987: Suppression of immune response induction in Peyer's patch lymphoid cells from mice infected with mouse hepatitis virus. Cellular Immunology 109(1): 97-103
Pikovski, M.A.; Ziffroni-Gallon, Y.; Witz, I.P. 1976: Suppression of immune response to sheep red blood cells in mice treated with preparations of a tumor cell component and in tumor-bearing mice. European Journal of Immunology 5(7): 447-450
Das, M.R.; Gridley, D.S.; Kettering, J.D. 1991: Suppression of immune responses by herpes virus type 2-transformed murine tumor cells. Immunology Letters 30(1): 37-45
Balcer, L.J.; McIntosh, K.R.; Nichols, J.C.; Drachman, D.B. 1991: Suppression of immune responses to acetylcholine receptor by interleukin 2-fusion toxin: in vivo and in vitro studies. Journal of Neuroimmunology 31(2): 115-122
Schnaper, H.W.; Aune, T.M. 1986: Suppression of immune responses to sheep erythrocytes by the lymphokine soluble immune response suppressor (SIRS) in vivo. Journal of Immunology 137(3): 863-867
Ueyama, S.; Kawauchi, H.; Mogi, G. 1988: Suppression of immune-mediated otitis media by T-suppressor cells. Archives of Otolaryngology--Head and Neck Surgery 114(8): 878-882
Lefford, M.J.; Mackaness, G.B. 1977: Suppression of immunity to Mycobacterium lepraemurium infection. Infection and Immunity 18(2): 363-369
Larcom, L.L.; Morris, T.E.; Smith, M.E. 1990: Suppression of immunocompetence and DNA repair capacity by exposure in commercial tanning salons. Journal of the National Cancer Institute 82(16): 1361
Sehon, A.H.; Lee, W.Y. 1979: Suppression of immunoglobulin e antibodies with modified allergens. Journal of Allergy and Clinical Immunology 64(4): 242-250
Paczek, L.; Schafer, R.M.; Teschner, M.; Heidland, A. 1990: Suppression of immunoglobulin and interleukin-6 production from peripheral blood mononuclear cells by dialysis membranes. Asaio Transactions 36(3): 459-461
Banerjee, D.; Baril, J.; Bell, D.A.; McFarlane, D.; Karim, R. 1988: Suppression of immunoglobulin production by germinal centre HNK-1+ CD3+ cells. Advances in Experimental Medicine and Biology 237: 421-425
Schwartz, S.A.; Shou, L.; Good, R.A.; Choi, Y.S. 1977: Suppression of immunoglobulin synthesis and secretion by peripheral blood lymphocytes from normal donors. Proceedings of the National Academy of Sciences of the United States of America 74(5): 2099-2103
Kakumu, S.; Fukui, K.; Yoshioka, K.; Murakami, H. 1986: Suppression of immunoglobulin synthesis by activated B cells in chronic active liver diseases and primary biliary cirrhosis. Gastroenterologia Japonica 21(1): 23-29
Poindexter, N.J.; Schlievert, P.M. 1986: Suppression of immunoglobulin-secreting cells from human peripheral blood by toxic-shock-syndrome toxin-1. Journal of Infectious Diseases 153(4): 772-779
Ho, W.K.; Cheung, K.W.; Leung, K.N.; Wen, H.L. 1986: Suppression of immunological functions in morphine addicted mice. Nida Research Monograph 75: 599-602
Bliznakov, E.G. 1979: Suppression of immunological responsiveness in aged mice and its relationship with coenzyme Q deficiency. Advances in Experimental Medicine and Biology 121(A): 361-369
Matsuo, K.; Kuniyasu, C.; Yamada, S.; Susumi, S.; Yamamoto, S. 1978: Suppression of immunoresponses to Haemophilus gallinarum with nonviable Mycoplasma gallisepticum in chickens. Avian Diseases 22(4): 552-561
Orosz, C.G.; Ferguson, R.M. 1985: Suppression of in vitro CML generation by alloactivated lymphocytes: analysis of antigen-nonspecific suppressive mechanisms. Journal of Immunology 134(1): 45-50
Thorley-Lawson, D.A.; Chess, L.; Strominger, J.L. 1978: Suppression of in vitro Epstein-Barr virus infection: a new role for adult human T-lymphocytes. Iarc Scientific Publications 1978(24 Part 2): 623-626
Johnson, H.M.; Ohtsuki, K. 1979: Suppression of in vitro antibody response by ribosome-associated factor(s) from interferon-treated cells. Cellular Immunology 44(1): 125-130
Bendinelli, M.; Matteucci, D.; Toniolo, A.; Friedman, H. 1979: Suppression of in vitro antibody response by spleen cells of mice infected with Friend-associated lymphatic leukemia virus. Infection and Immunity 24(1): 1-6
Gisler, R.H.; Fridman, W.H. 1975: Suppression of in vitro antibody synthesis by immunoglobulin-binding factor. Journal of Experimental Medicine 142(2): 507-517
Orosz, C.G.; Ferguson, R.M. 1986: Suppression of in vitro cell-mediated lympholysis generation by alloactivated lymphocytes. Examination of radioresistant suppressive activity. Transplantation 41(1): 69-75
Furst, A.S.; Becker, F.F. 1991: Suppression of in vitro chemical transformation by the carcinogenesis-promoting, viable yellow gene Avy. Carcinogenesis 12(7): 1157-1160
Shimizu, F.; Satoh, J.; Tada, M.; Kumagai, K. 1978: Suppression of in vitro growth of virulent and avirulent herpes simplex viruses by cell-mediated immune mechanisms, antibody, and interferon. Infection and Immunity 22(3): 752-757
Ishiguro, A.; Nakahata, T.; Amano, Y.; Koike, K.; Komiyama, A.; Shimbo, T. 1992: Suppression of in vitro hemopoiesis by the monocytes in a patient with aplastic anemia associated with hepatitis. Japanese Journal of Clinical Hematology 33(1): 87-92
Kojima, K.; Matsuyama, T.; Tanaka, H. 1986: Suppression of in vitro human antithyroglobulin antibody secretion by private and cross-reactive anti-idiotypic antibodies. Clinical Immunology and Immunopathology 39(2): 337-344
Ozkan, A.N.; Ninnemann, J.L. 1985: Suppression of in vitro lymphocyte and neutrophil responses by a low molecular weight suppressor active peptide from burn-patient sera. Journal of Clinical Immunology 5(3): 172-179
Damrow, T.A.; Williams, J.C.; Waag, D.M. 1985: Suppression of in vitro lymphocyte proliferation in C57BL/10 ScN mice vaccinated with phase i Coxiella burnetii. Infection and Immunity 47(1): 149-156
Dunmire, C.; Ruckdeschel, J.C.; Mardiney, M.R. 1975: Suppression of in vitro lymphocyte responsiveness to purified protein derivative by measles virus. a reexploration of the phenomenon. Cellular Immunology 20(2): 205-217
Huget, R.P.; Flad, H.D.; Opitz, H.G. 1977: Suppression of in vitro primary immune response by L1210 cells and their culture supernatant: evidence for cytotoxic effects. Cellular Immunology 29(1): 210-215
Koide, J.; Takeuchi, T.; Hosono, O.; Takano, M.; Abe, T. 1988: Suppression of in vitro production of anti-U1-ribonucleoprotein antibody by monoclonal anti-idiotypic antibody to anti-U1-ribonucleoprotein antibody. Scandinavian Journal of Immunology 28(6): 687-696
Strom, T.B.; Carpenter, C.B.; Cragoe, E.J.; Norris, S.; Devlin, R.; Perper, R.J. 1977: Suppression of in vivo and in vitro alloimmunity by prostaglandins. Transplantation Proceedings 9(1): 1075-1079
Sadahira, Y.; Mori, M.; Awai, M. 1986: Suppression of in vivo granulopoiesis by anti-asialo GM1 serum. Acta Pathologica Japonica 36(1): 23-33
Eisman, J.A.; Barkla, D.H.; Tutton, P.J. 1987: Suppression of in vivo growth of human cancer solid tumor xenografts by 1,25-dihydroxyvitamin D3. Cancer Research 47(1): 21-25
Finkelman, F.D.; Katona, I.M.; Urban, J.F.; Snapper, C.M.; Ohara, J.; Paul, W.E. 1986: Suppression of in vivo polyclonal IgE responses by monoclonal antibody to the lymphokine B-cell stimulatory factor 1. Proceedings of the National Academy of Sciences of the United States of America 83(24): 9675-9678
Kennedy, R.C.; Dreesman, G.R.; Butel, J.S.; Lanford, R.E. 1985: Suppression of in vivo tumor formation induced by simian virus 40-transformed cells in mice receiving antiidiotypic antibodies. Journal of Experimental Medicine 161(6): 1432-1449
Riley, E.M.; MacLennan, C.; Wiatkowski, D.K.; Greenwood, B.M. 1989: Suppression of in-vitro lymphoproliferative responses in acute malaria patients can be partially reversed by indomethacin. Parasite Immunology 11(5): 509-517
Okishige, K.; Andrews, T.C.; Friedman, P.L. 1991: Suppression of incessant polymorphic ventricular tachycardia by selective intracoronary ethanol infusion. Pacing and Clinical Electrophysiology: Pace 14(2 Part 1): 188-195
McAreavey, D.; Fananapazir, L. 1992: Suppression of incessant ventricular tachycardia in hypertrophic cardiomyopathy associated with improvement of severe left ventricular dysfunction. Pacing and Clinical Electrophysiology: Pace 15(11 Part 1): 1642-1645
Näslund, M.; Ehrenberg, L. 1978: Suppression of induced beta-galactosidase synthesis by cysteamine and its reversion by gamma-irradiation in the presence of ascorbate. International Journal of Radiation Biology and Related Studies in Physics Chemistry and Medicine 34(5): 411-415
Nyman, S.; Schroeder, H.E.; Lindhe, J. 1979: Suppression of inflammation and bone resorption by indomethacin during experimental periodontitis in dogs. Journal of Periodontology 50(9): 450-461
Berezantsev, I.A. 1975: Suppression of inflammatory cellular reactions by helminth larvae and specificity of their encapsulation in host tissues. Doklady Akademii Nauk SSSR 220(1): 227-229
Yurchenko, L.V.; Abramova, T.V.; Ivanova, E.M.; Nevinsky, G.A.; Nomokonova, N.Y.; Fokina, T.N.; Vlassov, V.V. 1991: Suppression of influenza virus biopolymers functions and reproduction of the virus by oligodeoxynucleotide derivatives. Nucleic Acids Symposium Series 24: 301
Tresguerres, E.F.; Nandadasa, H.G.; Pritchard, R.H. 1975: Suppression of initiation-negative strains of Escherichia coli by integration of the sex factor F. Journal of Bacteriology 121(2): 554-561
Hosker, J.P.; Burnett, M.A.; Matthews, D.R.; Turner, R.C. 1988: Suppression of insulin secretion by falling plasma glucose levels is impaired in type 2 diabetes. Diabetic Medicine: a Journal of the British Diabetic Association 5(9): 856-860
Chernausek, S.D.; Dickson, B.A.; Smith, E.P.; Hoath, S.B. 1991: Suppression of insulin-like growth factor i during epidermal growth factor-induced growth retardation. American Journal of Physiology 260(3 Part 1): E416-E421
Kreutter, D.; Orena, S.J.; Andrews, K.M. 1989: Suppression of insulin-stimulated glucose transport in L6 myocytes by calcitonin gene-related peptide. Biochemical and Biophysical Research Communications 164(1): 461-467
Yepez-Lasso, R.; Duncan, J.S.; Shorvon, S.D. 1990: Suppression of inter-ictal spikes by CM40907. a double-blind placebo-controlled investigation and review of spike counting as a methodology for assessing the antiepileptic effect of drugs. Epilepsy Research 5(3): 247-250
Fujii, N.; Kimura, K.; Murakami, T.; Indoh, T.; Ishida, S.; Fujinaga, K.; Oguma, K. 1990: Suppression of interferon-induced oligo-2',5'-adenylate synthetase induction in persistent infection. Journal of General Virology 71: 3071-3074
Bragdon, A.C.; Kojima, H.; Wilson, W.A. 1992: Suppression of interictal bursting in hippocampus unleashes seizures in entorhinal cortex: a proepileptic effect of lowering [K+]o and raising [Ca2+]o. Brain Research 590(1-2): 128-135
Kobayashi, K.; Allred, C.; Yoshida, T. 1989: Suppression of interleukin 2 production by sera obtained from hypersensitivity granuloma-bearing mice with defective T cell-mediated immune responses. Immunobiology 178(4-5): 329-339
Reed, J.C.; Tadmori, W.; Kamoun, M.; Koretzky, G.; Nowell, P.C. 1985: Suppression of interleukin 2 receptor acquisition by monoclonal antibodies recognizing the 50 KD protein associated with the sheep erythrocyte receptor on human T lymphocytes. Journal of Immunology 134(3): 1631-1639
Sileghem, M.; Flynn, J.N. 1992: Suppression of interleukin 2 secretion and interleukin 2 receptor expression during tsetse-transmitted trypanosomiasis in cattle. European Journal of Immunology 22(3): 767-773
Santoli, D.; Phillips, P.D.; Colt, T.L.; Zurier, R.B. 1990: Suppression of interleukin 2-dependent human T cell growth in vitro by prostaglandin e (PGE) and their precursor fatty acids. Evidence for a PGE-independent mechanism of inhibition by the fatty acids. Journal of Clinical Investigation 85(2): 424-432
Akeson, A.L.; Schroeder, K.; Woods, C.; Schmidt, C.J.; Jones, W.D. 1991: Suppression of interleukin-1 beta and LDL scavenger receptor expression in macrophages by a selective protein kinase C inhibitor. Journal of Lipid Research 32(10): 1699-1707
Segerson, E.C.; Gunsett, F.C. 1990: Suppression of interleukin-2 mediated T-lymphocyte blastogenesis by bovine uterine secretions. American Journal of Reproductive Immunology 22(3-4): 117-123
Chopra, V.; Tyring, S.K. 1991: Suppression of interleukin-2 production and activity by factor(s) released by peripheral blood mononuclear cells during papillomavirus infections. Viral Immunology 4(4): 237-248
Cillari, E.; Liew, F.Y.; Lelchuk, R. 1986: Suppression of interleukin-2 production by macrophages in genetically susceptible mice infected with Leishmania major. Infection and Immunity 54(2): 386-394
Segerson, E.C. 1988: Suppression of interleukin-2-mediated T-lymphocyte blastogenesis by ovine uterine luminal protein. Biology of Reproduction 38(2): 256-263
Takagi, T.; Abe, T.; Tamada, H.; Yamaki, K.; Sakuragi, S. 1992: Suppression of interphotoreceptor retinoid-binding protein (IRBP)-induced experimental autoimmune uveitis by pretreatment with anti-idiotypic monoclonal antibody. Nippon Ganka Gakkai Zasshi 96(5): 606-612
Mizunoe, K.; Hiraki, M.; Nagano, Y.; Maehara, N. 1975: Suppression of intracellular multiplication of Mycobacterium tuberculosis by virus-inhibiting factor or interferon. Japanese Journal of Microbiology 19(3): 235-236
Stewart, C.J.; Coady, T.J. 1977: Suppression of intractable cough. British Medical Journal 1(6077): 1660-1661
Nagarkatti, M.; Nagarkatti, P.S. 1979: Suppression of intrinsic B-cell function in Dengue-infected mice. Experientia 35(11): 1518-1519
Khokha, R.; Zimmer, M.J.; Graham, C.H.; Lala, P.K.; Waterhouse, P. 1992: Suppression of invasion by inducible expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) in B16-F10 melanoma cells. Journal of the National Cancer Institute 84(13): 1017-1022
Pechstedt, P.H. 1986: Suppression of ipsilateral auditory pathways increases with increasing task load in commissurotomy subjects. Bulletin of Clinical Neurosciences 51: 73-76
McIntosh, M.A.; Pickett, C.L.; Chenault, S.S.; Earhart, C.F. 1978: Suppression of iron uptake deficiency in Escherichia coli K-12 by loss of two major outer membrane proteins. Biochemical and Biophysical Research Communications 81(4): 1106-1112
Fadrus, H.; Malý, J. 1975: Suppression of iron(III) interference in the determination of iron(II) in water by the 1,10-phenanthroline method. Analyst 100(1193): 549-554
Aoki, Y.; Nata, M.; Odaira, T.; Sagisaka, K. 1992: Suppression of ischemia-reperfusion injury by liposomal superoxide dismutase in rats subjected to tourniquet shock. International Journal of Legal Medicine 105(1): 5-9
Meyer, D.K.; Hertting, G.; Mittermayer, C. 1975: Suppression of isoprenaline-induced increase in plasma renin concentration by vasoconstrictors in rats with nonfunctioning Macula densa. Naunyn-Schmiedeberg's Archives of Pharmacology 290(2-3): 315-321
Rice, R.H.; Rong, X.H.; Chakravarty, R. 1988: Suppression of keratinocyte differentiation in SSC-9 human squamous carcinoma cells by benzo[a]pyrene, 12-O-tetradecanoylphorbol-13-acetate and hydroxyurea. Carcinogenesis 9(10): 1885-1890
Priestley, C.A.; Spencer, S.C.; Sawyer, G.J.; Fabre, J.W. 1992: Suppression of kidney allograft rejection across full MHC barriers by recipient-specific antibodies to class Ii MHC antigens. Transplantation 53(5): 1024-1032
Cottrell, G.A.; Robertson, H.A. 1987: Suppression of kindled seizures by cysteamine: dependence on injection-to-kindled seizure interval. European Journal of Pharmacology 134(2): 225-228
De Villiers, V.P. 1975: Suppression of labor contractions by intravenous hexoprenaline: a preliminary investigation in the Paarl Hospital. South African Medical Journal 49(10): 345-348
Shaaban, M.M. 1975: Suppression of lactation by an antiestrogen, tamoxifen. European Journal of Obstetrics Gynecology and Reproductive Biology 4(5): 167-169
Winter, S. 1978: Suppression of lactation by estrogens. Harefuah 95(2): 93-94
Russell, T.V.; Chalmers, H.J. 1975: Suppression of lactation without oestrogens. Nursing Mirror and Midwives Journal 141(9): 60-62
England, M.J.; Tjallinks, A.; Hofmeyr, J.; Harber, J. 1988: Suppression of lactation. a comparison of bromocriptine and prostaglandin E2. Journal of Reproductive Medicine 33(7): 630-632
Annis, B.; Krisnowardojo, S.; Atmosoedjono, S.; Supardi, P. 1989: Suppression of larval Aedes aegypti populations in household water storage containers in Jakarta, Indonesia, through releases of first-instar Toxorhynchites splendens larvae. Journal of the American Mosquito Control Association 5(2): 235-238
Pienkowski, M.M.; Norman, P.S.; Lichtenstein, L.M. 1985: Suppression of late-phase skin reactions by immunotherapy with ragweed extract. Journal of Allergy and Clinical Immunology 76(5): 729-734
Masaki, S.; Watanabe, T. 1988: Suppression of lens gamma-crystallin encoded by Len-1 in the mutant mouse with eye lens obsolescence (Elo). Experimental Eye Research 47(5): 727-735
Lynch, J.J.; Heaney, L.A.; Wallace, A.A.; Gehret, J.R.; Selnick, H.G.; Stein, R.B. 1990: Suppression of lethal ischemic ventricular arrhythmias by the class IIi agent E4031 in a canine model of previous myocardial infarction. Journal of Cardiovascular Pharmacology 15(5): 764-775
Wu, K.F.; Song, Y.H.; Li, H.Z.; Rao, Q.; Zhu, Y.M. 1991: Suppression of leukemic growth by HFdi and LAI-615. Annals of the new York Academy of Sciences 628: 153-155
Pottathil, R.; Meier, H.; Huebner, R.J. 1978: Suppression of leukemogenesis in hairless mice by anti-type C viral immune gamma globulins. Die Naturwissenschaften 65(8): 443-444
Van Epps, D.E.; Williams, R.C. 1976: Suppression of leukocyte chemotaxis by human IgA myeloma components. Journal of Experimental Medicine 144(5): 1227-1242
Warden, G.D.; Mason, A.D.; Pruitt, B.A. 1975: Suppression of leukocyte chemotaxis in vitro by chemotherapeutic agents used in the management of thermal injuries. Annals of Surgery 181(3): 363-369
Lomnitzer, R.; Rabson, A.R. 1979: Suppression of leukocyte inhibitory factor (LIF) production and [3H]thymidine incorporation by concanavalin A-activated mononuclear cells. Cellular Immunology 43(1): 41-47
Borisenko, I.D.; Novikov, D.K.; Shein, I.A. 1978: Suppression of leukocyte migration in bladder cancer with tumor antigens before and after surgery. Urologiia i Nefrologiia 2: 26-29
Green, F.A.; Gustafsson, B.; Claesson, H.E. 1988: Suppression of leukotriene synthesis in human leukocytes by a urea extract of Bordetella pertussis: evidence for mediation by adenylate cyclase toxin. Toxicon: Official Journal of the International Society on Toxinology 26(12): 1187-1191
Miyahara, M.; Tatsumi, Y. 1990: Suppression of lipid peroxidation by sho-saiko-to and its components in rat liver subcellular membranes. Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan 110(6): 407-413
Kawakami, M.; Kondo, Y.; Imai, Y.; Hashiguchi, M.; Ogawa, H.; Hiragun, A.; Aotsuka, S.; Shibata, S.; Oda, T.; Murase, T. 1991: Suppression of lipoprotein lipase in 3T3-L1 cells by a mediator produced by SEKi melanoma, a cachexia-inducing human melanoma cell line. Journal of Biochemistry 109(1): 78-82
Castellano, T.J.; Schiffman, R.L.; Jacob, M.C.; Loeb, J.N. 1978: Suppression of liver cell proliferation by glucocorticoid hormone: a comparison of normally growing and regenerating tissue in the immature rat. Endocrinology 102(4): 1107-1112
Takahashi, H.; Takeshita, T.; Yokomuro, K. 1988: Suppression of liver regeneration resulting from intravenous injection of splenic glass adherent cells activated by poly I:C. Immunobiology 176(3): 217-227
Das, N.; Basu, M.K.; Das, M.K. 1987: Suppression of liver uptake of orally fed liposomes by injection (i.p.) of dextran sulfate 500. Bioscience Reports 7(6): 465-470
Davis, D.P.; Gomez, M.P.; Barton, S.L.; Montano, R.M.; Burchiel, S.W. 1991: Suppression of local gut-associated and splenic mitogen responsiveness of lymphoid cells following oral exposure of B6C3F1 mice to 7,12-dimethylbenz[a]anthracene. Fundamental and Applied Toxicology: Official Journal of the Society of Toxicology 17(2): 429-431
Hamilton, S.R.; Yardley, J.H.; Brown, G.D. 1979: Suppression of local intestinal immunoglobulin a immune response to cholera toxin by subcutaneous administration of cholera toxoids. Infection and Immunity 24(2): 422-426
Ahlenius, S.; Fernandez-Guasti, A.; Hjorth, S.; Larsson, K. 1986: Suppression of lordosis behavior by the putative 5-HT receptor agonist 8-OH-DPAT in the rat. European Journal of Pharmacology 124(3): 361-363
Zasorin, N.L. 1975: Suppression of lordosis in the hormone-primed female hamster by electrical stimulation of the septal area. Physiology and Behavior 14(5): 595
Kolb, H.; Oschilewski, M.; Schwab, E.; Greulich, B.; Roos, P.; Kiesel, U. 1986: Suppression of low-dose streptozotocin-induced diabetes by immunomodulatory lectins. Diabetes Research 3(4): 183-186
Sridaran, R.; Mahesh, V.B. 1989: Suppression of luteal estradiol receptors and progesterone synthesis by a gonadotropin-releasing hormone agonist (WY-40972) during midgestation. Biology of Reproduction 40(2): 276-282
Fraser, H.M.; Nestor, J.J.; Vickery, B.H. 1987: Suppression of luteal function by a luteinizing hormone-releasing hormone antagonist during the early luteal phase in the stumptailed macaque monkey and the effects of subsequent administration of human chorionic gonadotropin. Endocrinology 121(2): 612-618
Fraser, H.M.; Baird, D.T.; McRae, G.I.; Nestor, J.J.; Vickery, B.H. 1985: Suppression of luteal progesterone secretion in the stumptailed macaque by an antagonist analogue of luteinizing hormone releasing hormone. Journal of Endocrinology 104(2): R1-R4
Eckstein, B.; Yehud, S.; Shani, J.; Goldhaber, G. 1976: Suppression of luteinizing hormone release by 5alpha-androstane-3alpha, 17 beta-diol and its 3 beta epimer in immature ovariectomized rats. Journal of Endocrinology 70(1): 25-30
Uhteg, L.C.; Kupiec-Weglinski, J.W.; Tilney, N.L.; Carpenter, C.B. 1987: Suppression of lymph node CTL generation by spleen cells from cyclosporine-treated cardiac-allografted rats. Transplantation Proceedings 19(1 Part 2): 1189-1190
Gatti, R.A.; Cousineau, M.; Naeim, F.; Leibold, W. 1979: Suppression of lymphoblastoid cell line proliferation by antisera to HLA-DR and other HLA antigens. Tissue Antigens 14(3): 213-222
Chiao, J.W.; Heil, M.; Arlin, Z.; Lutton, J.D.; Choi, Y.S.; Leung, K. 1986: Suppression of lymphocyte activation and functions by a leukemia cell-derived inhibitor. Proceedings of the National Academy of Sciences of the United States of America 83(10): 3432-3436
Murray, M.K.; Segerson, E.C.; Hansen, P.J.; Bazer, F.W.; Roberts, R.M. 1987: Suppression of lymphocyte activation by a high-molecular-weight glycoprotein released from preimplantation ovine and porcine conceptuses. American Journal of Reproductive Immunology and Microbiology: Ajrim 14(2): 38-44
Bayer, B.M.; Hernandez, M.; Irvin, L. 1990: Suppression of lymphocyte activity after acute morphine administration appears to be glucocorticoid independent. Progress in Clinical and Biological Research 325: 273-282
Parhar, R.S.; Kennedy, T.G.; Lala, P.K. 1988: Suppression of lymphocyte alloreactivity by early gestational human decidua. I. Characterization of suppressor cells and suppressor molecules. Cellular Immunology 116(2): 392-410
Lala, P.K.; Kennedy, T.G.; Parhar, R.S. 1988: Suppression of lymphocyte alloreactivity by early gestational human decidua. II. Characterization of the suppressor mechanisms. Cellular Immunology 116(2): 411-422
Metzger, Z.; Hoffeld, J.T.; Charon, J.; Mergenhagen, S.E. 1987: Suppression of lymphocyte and fibroblast proliferation by Actinomyces viscosus-activated murine macrophages. Journal of Periodontal Research 22(6): 456-460
Derbyshire, J.B.; De Laat, A. 1991: Suppression of lymphocyte blastogenesis by porcine interferon-alpha. Research in Veterinary Science 50(3): 376-378
Dong, Y.H. 1987: Suppression of lymphocyte function in vitro with placental gamma-globulin. Zhonghua Yi Xue Za Zhi 67(7): 385-388
Dube, V.E.; Kallio, P.; Hakim, A. 1988: Suppression of lymphocyte function with breast carcinoma I-active glycopeptides. Immunological Investigations 17(1): 19-24
Issekutz, T.B.; Stoltz, J.M. 1985: Suppression of lymphocyte proliferation by Pseudomonas aeruginosa: mediation by Pseudomonas-activated suppressor monocytes. Infection and Immunity 48(3): 832-838
Roth, T.L.; White, K.L.; Thompson, D.L.; Barry, B.E.; Capehart, J.S.; Colborn, D.R.; Rabb, M.H. 1990: Suppression of lymphocyte proliferation by a greater than 30,000 molecular weight factor in horse conceptus-conditioned medium. Biology of Reproduction 43(2): 298-304
Oostendorp, R.A.; Schaaper, W.M.; Post, J.; Von Blomberg, B.M.; Meloen, R.H.; Scheper, R.J. 1992: Suppression of lymphocyte proliferation by a retroviral p15E-derived hexapeptide. European Journal of Immunology 22(6): 1505-1511
Wyatt, C.R.; Law, L.; Magnuson, J.A.; Griswold, M.D.; Magnuson, N.S. 1988: Suppression of lymphocyte proliferation by proteins secreted by cultured Sertoli cells. Journal of Reproductive Immunology 14(1): 27-40
Miyamura, T.; Uchida, S. 1987: Suppression of lymphocyte proliferation by serum lipoproteins in chronic liver diseases. Nihon Shokakibyo Gakkai Zasshi 84(6): 1258-1264
Bey, R.F.; Johnson, R.C.; Fitzgerald, T.J. 1979: Suppression of lymphocyte response to concanavalin a by mucopolysaccharide material from Treponema pallidum-infected rabbits. Infection and Immunity 26(1): 64-69
Mihas, A.A.; Gibson, R.G.; Hirschowitz, B.I. 1975: Suppression of lymphocyte transformation by 16, (16) dimethyl prostaglandin E2 and unsaturated fatty acids. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 149(4): 1026-1028
Cutts, J.L.; Bankhurst, A.D. 1989: Suppression of lymphoid cell function in vitro by inhibition of 3-hydroxy-3-methylglutaryl coenzyme a reductase by lovastatin. International Journal of Immunopharmacology 11(8): 863-869
Varesio, L.; Herberman, R.B.; Gerson, J.M.; Holden, H.T. 1979: Suppression of lymphokine production by macrophages infiltrating murine virus-induced tumors. International Journal of Cancer 24(1): 97-102
Yin, L.; Chain, B.M. 1991: Suppression of lymphokine production in anti-minor histocompatibility antigen responses. Cytokine 3(1): 5-11
Ottonello, L.; Dallegri, F.; Dapino, P.; Patrone, F.; Sacchetti, C. 1991: Suppression of lymphokine-activated killer (LAK) cell function by neutrophil polymorphonuclear leukocytes. Journal of Clinical and Laboratory Immunology 34(1): 37-40
Chakraborty, N.G.; Sporn, J.R.; Pasquale, D.R.; Ergin, M.T.; Mukherji, B. 1991: Suppression of lymphokine-activated killer cell generation by tumor-infiltrating lymphocytes. Clinical Immunology and Immunopathology 59(3): 407-416
Shau, H.Y.; Kim, A. 1988: Suppression of lymphokine-activated killer induction by neutrophils. Journal of Immunology 141(12): 4395-4402
Ullrich, S.E. 1985: Suppression of lymphoproliferation by hapten-specific suppressor T lymphocytes from mice exposed to ultraviolet radiation. Immunology 54(2): 343-352
Laughter, A.H.; Twomey, J.J. 1977: Suppression of lymphoproliferation by high concentrations of normal human mononuclear leukocytes. Journal of Immunology 119(1): 173-179
Taylor, G.M.; Fergusson, W.D.; Harris, R. 1979: Suppression of lymphoproliferative responses to alloantigens by autologous AML cells. Clinical and Experimental Immunology 35(1): 53-61
Kato, T.; Kitaura, M.; Inaba, K.; Watanabe, Y.; Kawade, Y.; Muramatsu, S. 1992: Suppression of macrophage Ia antigen expression by endogenous interferon-alpha/beta. Journal of Interferon Research Spec No: 29-41
Bernton, E.W.; Meltzer, M.S.; Holaday, J.W. 1988: Suppression of macrophage activation and T-lymphocyte function in hypoprolactinemic mice. Science 239(4838): 401-404
Dimitriu, A. 1976: Suppression of macrophage arming by corticosteroids. Cellular Immunology 21(1): 79-87
Dickneite, G.; Schorlemmer, H.U.; Sedlacek, H.H.; Falk, W.; Ulrichs, K.; Müller-Ruchholtz, W. 1987: Suppression of macrophage function and prolongation of graft survival by the new guanidinic-like structure, 15-deoxyspergualin. Transplantation Proceedings 19(1 Pt 2): 1301-1304
Archer, D.L.; Bukovic-Wess, J.A.; Smith, B.G. 1977: Suppression of macrophage-dependent T-lymphocyte function(s) by gallic acid, a food additive metabolite. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 156(3): 465-469
Watanabe, T.; Yamashita, T.; Sendo, F. 1990: Suppression of macrophage-mediated antibody-dependent killing of Schistosoma mansoni larvae by concanavalin a stimulated spleen cell-derived factor(s). Parasite Immunology 12(3): 309-319
Gruber, S.A.; Migliori, R.J.; Hoffman, R.A.; Ascher, N.L.; Simmons, R.L. 1987: Suppression of macrophage-mediated lymphocyte recruitment by local but not systemic steroids. Current Surgery 44(5): 406-408
Lewis, A.N.; Ponnampalam, J.T. 1975: Suppression of malaria with monthly administration of combined sulphadoxine and pyrimethamine. Annals of Tropical Medicine and Parasitology 69(1): 1-12
Fawcett, P.T.; Fawcett, L.B.; Doughty, R.A.; Coleman, R.M. 1989: Suppression of malaria-induced autoimmunity by immunization with cryoglobulins. Cellular Immunology 118(1): 192-198
Shrenker, P.; Bartke, A. 1985: Suppression of male copulatory behavior by delta 9-THC is not dependent on changes in plasma testosterone or hypothalamic dopamine or serotonin content. Pharmacology Biochemistry and Behavior 22(3): 415-420
Davis-daSilva, M.; Wallen, K. 1989: Suppression of male rhesus testicular function and sexual behavior by a gonadotropin-releasing-hormone agonist. Physiology and Behavior 45(5): 963-968
Yeowell, H.N.; Waxman, D.J.; LeBlanc, G.A.; Linko, P.; Goldstein, J.A. 1989: Suppression of male-specific cytochrome P450 2c and its mRNA by 3,4,5,3',4',5'-hexachlorobiphenyl in rat liver is not causally related to changes in serum testosterone. Archives of Biochemistry and Biophysics 271(2): 508-514
Carney, D.N.; Edgell, C.J.; Gazdar, A.F.; Minna, J.D. 1979: Suppression of malignancy in human lung cancer (A549/8) times mouse fibroblast (3T3-4E) somatic cell hybrids. Journal of the National Cancer Institute 62(2): 411-415
Louis, C.J.; Rose, G.B. 1978: Suppression of malignancy in mouse-man hybrid cells. Pathology 10(4): 343-350
Welsch, C.W.; Lambrecht, L.K.; Hassett, C.C. 1977: Suppression of mammary tumorigenesis in C3H/He mice by ovariectomy or treatment with 2-bromo-alpha-ergocryptine: a comparison. Journal of the National Cancer Institute 58(4): 1135-1138
Brotherton, J. 1990: Suppression of maternal pituitary thyroid-stimulating hormone during pregnancy. Human Reproduction 5(4): 471-475
Pence, H.; Petty, W.M.; Rocklin, R.E. 1975: Suppression of maternal responsiveness to paternal antigen by maternal plasma. Journal of Immunology 114(1 Part 2): 525-528
Dessypris, E.N.; Gleaton, J.H.; Sawyer, S.T.; Armstrong, O.L. 1987: Suppression of maturation of megakaryocyte colony forming unit in vitro by a platelet-released glycoprotein. Journal of Cellular Physiology 130(3): 361-368
Pau, K.Y.; Hess, D.L.; Kaynard, A.H.; Ji, W.Z.; Gliessman, P.M.; Spies, H.G. 1989: Suppression of mediobasal hypothalamic gonadotropin-releasing hormone and plasma luteinizing hormone pulsatile patterns by phentolamine in ovariectomized rhesus macaques. Endocrinology 124(2): 891-898
Wrathall, J.R.; Newcomb, E.W.; Balint, R.; Zeitz, L.; Silagi, S. 1975: Suppression of melanoma cell tyrosinase activity and tumorigenicity after incorporation of bromouracil for one or two cell divisions. Journal of Cellular Physiology 86 Suppl. 2(3 Pt 2): 581-592
Arendt, J.; Ravault, J.P. 1988: Suppression of melatonin secretion in Ile-de-France rams by different light intensities. Journal of Pineal Research 5(3): 245-250
Fuchs, F.; Chan, W.Y.; Dawood, M.Y. 1979: Suppression of menstrual prostaglandins and relief of dysmenorrhea with ibuprofen. Acta Obstetricia et Gynecologica Scandinavica. Suppl 87: 91-92
Lacraz, S.; Nicod, L.; Galve-de Rochemonteix, B.; Baumberger, C.; Dayer, J.M.; Welgus, H.G. 1992: Suppression of metalloproteinase biosynthesis in human alveolar macrophages by interleukin-4. Journal of Clinical Investigation 90(2): 382-388
Toussi, H.R.; Schatz, R.A.; Waszczak, B.L. 1987: Suppression of methionine sulfoximine seizures by intranigral gamma-vinyl GABA injection. European Journal of Pharmacology 137(2-3): 261-264
Van der Nat, J.M.; Beijnen, J.H.; van Dijk, H.; Underberg, W.J.; Labadie, R.P. 1986: Suppression of migration inhibition factor (MIF) production by mitomycins in vitro. Immunobiology 172(1-2): 120-127
Aw, T.Y.; Andersson, B.S.; Jones, D.P. 1987: Suppression of mitochondrial respiratory function after short-term anoxia. American Journal of Physiology 252(4 Part 1): C362-C368
Waxman, M.F.; Knight, J.A.; Perlman, P.S. 1979: Suppression of mitochondrially-determined resistance to chloramphenicol and paromomycin by nuclear genes in Saccharomyces cerevisiae. Molecular and General Genetics: Mgg 167(3): 243-250
Yamage, M.; Evans, C.H. 1989: Suppression of mitogen- and antigen-induced lymphocyte proliferation by lanthanides. Experientia 45(11-12): 1129-1131
Lee, L.F.; Sharma, J.M.; Nazerian, K.; Witter, R.L. 1978: Suppression of mitogen-induced proliferation of normal spleen cells by macrophages from chickens inoculated with Marek's disease virus. Journal of Immunology 120(5): 1554-1559
Podleski, W.K.; Wardlow, M. 1979: Suppression of mitogen-induced, cell-mediated cytotoxicity by prostaglandin F2 alpha in bronchial asthma. Annals of Allergy 42(6): 365-367
Inouye, T.; Sasaki, Y.F.; Imanishi, H.; Watanebe, M.; Ohta, T.; Shirasu, Y. 1988: Suppression of mitomycin C-induced micronuclei in mouse bone marrow cells by post-treatment with vanillin. Mutation Research 202(1): 93-95
McIntyre, J.A.; Faulk, W.P. 1978: Suppression of mixed lymphocyte cultures by antibodies against human trophoblast membrane antigens. Transplantation Proceedings 10(4): 919-922
Nakayama, E.; Asano, S.; Kodo, H.; Miwa, S. 1985: Suppression of mixed lymphocyte reaction by cells of human first trimester pregnancy endometrium. Journal of Reproductive Immunology 8(1): 25-31
Kobayashi, H.; Mori, T.; Suzuki, A.; Nishimura, T.; Nishimoto, H.; Harada, M. 1979: Suppression of mixed lymphocyte reaction by progesterone and estradiol-17beta. American Journal of Obstetrics and Gynecology 134(3): 255-259
Saffran, D.C.; Singhal, S.K. 1991: Suppression of mixed lymphocyte reactivity by murine bone-marrow-derived suppressor factor--inhibition of proliferation due to a deficit in IL-2 production. Transplantation 52(4): 685-690
Kiczka, W.; Szkaradkiewicz, A. 1986: Suppression of monocyte mediated anti U562 cytotoxicity by soluble factors in the serum of cancer patients and in the supernatant of K562 cell culture. Immunology Letters 13(3): 127-131
Horneff, G.; Emmrich, F.; Kalden, J.R.; Burmester, G.R. 1991: Suppression of monocyte-macrophage activation by anti-CD4 therapy in patients with chronic polyarthritis. Immunitat und Infektion 19(2): 55-56
Tate, G.A.; Mandell, B.F.; Karmali, R.A.; Laposata, M.; Baker, D.G.; Schumacher, H.R.; Zurier, R.B. 1988: Suppression of monosodium urate crystal-induced acute inflammation by diets enriched with gamma-linolenic acid and eicosapentaenoic acid. Arthritis and Rheumatism 31(12): 1543-1551
Brown, M.C.; Ironton, R. 1977: Suppression of motor nerve terminal sprouting in partially denervated mouse muscles. Journal of Physiology 272(1): 70P-71P
Da Costa, P.S.; de Macedo, M.S.; Perini, A. 1990: Suppression of mouse IgE response by immune complexes. Journal of Allergy and Clinical Immunology 86(4 Part 1): 496-502
Austin, T.; Ma, A.; Datta, M.C.; Ortega, J.A.; Shore, N.A.; Dukes, P.P. 1979: Suppression of mouse erythroid colony formation by L1210 leukemia cells. Experimental Hematology 7(2): 63-73
Jordan, V.C.; Lababidi, M.K.; Langan-Fahey, S. 1991: Suppression of mouse mammary tumorigenesis by long-term tamoxifen therapy. Journal of the National Cancer Institute 83(7): 492-496
OBoyle, M. 1976: Suppression of mouse-killing in rats following irradiation. Perceptual and Motor Skills 42(2): 511-514
Dehlawi, M.S.; Wakelin, D. 1988: Suppression of mucosal mastocytosis by Nematospiroides dubius results from an adult worm-mediated effect upon host lymphocytes. Parasite Immunology 10(1): 85-95
Estis, L.F.; Temin, H.M. 1979: Suppression of multiplication of avian sarcoma virus by rapid spread of transformation-defective virus of the same subgroup. Journal of Virology 31(2): 389-397
Whittall, N.; Moran, D.M.; Wheeler, A.W.; Cottam, G.P. 1985: Suppression of murine IgE responses with amino acid polymer/allergen conjugates. I. Preparation of poly-(N-methylglycine)/grass pollen extract conjugates using 4-(methylmercapto)phenyl-succinimidyl succinate as coupling reagent. International Archives of Allergy and Applied Immunology 76(4): 354-360
Wheeler, A.W.; Henderson, D.C.; Garman, A.J.; Moran, D.M. 1985: Suppression of murine IgE responses with amino acid polymer/allergen conjugates. II. Suppressive activities in adjuvant-induced IgE responses. International Archives of Allergy and Applied Immunology 76(4): 361-368
Cook, R.M.; Henderson, D.C.; Wheeler, A.W.; Moran, D.M. 1986: Suppression of murine IgE responses with amino acid polymer/allergen conjugates. III. Activity in vitro. International Archives of Allergy and Applied Immunology 80(4): 355-360
Moran, D.M.; Wheeler, A.W.; Henderson, D.C.; Whittall, N. 1986: Suppression of murine IgE responses with amino acid polymer/allergen conjugates. IV. Suppressive activities in established IgE model systems. International Archives of Allergy and Applied Immunology 81(4): 357-362
Henderson, D.C.; Wheeler, A.W.; Moran, D.M. 1987: Suppression of murine IgE responses with amino acid polymer/allergen conjugates. V. by intranasal administration. International Archives of Allergy and Applied Immunology 82(2): 208-211
Milisauskas, V.K.; Cudkowicz, G.; Nakamura, I. 1986: Suppression of murine NK activity induced by Corynebacterium parvum: further characterization and abrogation of suppressor cells. Cancer Immunology Immunotherapy: Cii 21(1): 51-57
Patel, M.R.; Rogers, T.J.; Linna, T.J. 1987: Suppression of murine alloimmune cytolytic T lymphocyte development by spleen cells incubated with staphylococcal enterotoxin B in vitro. Transplantation Proceedings 19(1 Pt 1): 288-289
Cooper, S.M.; Sriram, S.; Ranges, G.E. 1988: Suppression of murine collagen-induced arthritis with monoclonal anti-Ia antibodies and augmentation with IFN-gamma. Journal of Immunology 141(6): 1958-1962
House, R.V.; Pallardy, M.J.; Dean, J.H. 1989: Suppression of murine cytotoxic T-lymphocyte induction following exposure to 7,12-dimethylbenz[A]anthracene: dysfunction of antigen recognition. International Journal of Immunopharmacology 11(2): 207-215
Momozaki, N.; Ogura, H.; Miyazaki, J.; Matsuhashi, S.; Joh, K.; Kimura, G.; Tabuchi, K.; Hori, K. 1991: Suppression of murine leukemia virus-mediated 3Y1 cell fusion by expression of mouse MHC class i. Archives of Virology 119(1-2): 43-52
Zouali, M.; Jolivet, M.; Leclerc, C.; Ravisse, P.; Audibert, F.; Eyquem, A.; Chedio, L. 1985: Suppression of murine lupus autoantibodies to DNA by administration of muramyl dipeptide and syngeneic anti-DNA IgG. Journal of Immunology 135(2): 1091-1096
Nishihara, T.; Koga, T.; Hamada, S. 1988: Suppression of murine macrophage interleukin-1 release by the polysaccharide portion of Haemophilus actinomycetemcomitans lipopolysaccharide. Infection and Immunity 56(3): 619-625
Maltese, W.A.; Defendini, R.; Green, R.A.; Sheridan, K.M.; Donley, D.K. 1985: Suppression of murine neuroblastoma growth in vivo by mevinolin, a competitive inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme a reductase. Journal of Clinical Investigation 76(5): 1748-1754
Huebner, R.J.; Gilden, R.V.; Lane, W.T.; Toni, R.; Trimmer, R.W.; Hill, P.R. 1976: Suppression of murine type-C RNA virogenes by type-specific oncornavirus vaccines: prospects for prevention of cancer. Proceedings of the National Academy of Sciences of the United States of America 73(2): 620-624
Dantzig, J.A.; Goldman, Y.E. 1985: Suppression of muscle contraction by vanadate. Mechanical and ligand binding studies on glycerol-extracted rabbit fibers. Journal of General Physiology 86(3): 305-327
Cherepenko, E.I.; Maliuta, S.S. 1977: Suppression of mutations arising during transformation of Bacillus subtilis cells using foreign DNA. Tsitologiia i Genetika 11(4): 306-309
Koizumi, S.; Tachinami, T.; Saikawa, Y.; Taniguchi, N. 1988: Suppression of myeloid hematopoiesis by leukemic natural killer cells bearing a Leu-11+, Leu-7- phenotype: interferon-gamma as a possible mediator. Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 51(1): 81-93
Schreiber, H.; Leibson, P. 1978: Suppression of myeloma growth in vitro by anti-idiotypic antibodies: inhibition of DNA synthesis and colony formation. Journal of the National Cancer Institute 60(1): 225-233
Kawano, S.; Tatsumi, E.; Yoneda, N.; Yamaguchi, N. 1992: Suppression of myeloperoxidase gene expression by gamma-interferon. Human Cell 5(3): 282-286
Sandra, A.; Leon, M.A.; Przybylski, R.J. 1977: Suppression of myoblast fusion by concanavalin A: possible involvement of membrane fluidity. Journal of Cell Science 28: 251-272
Toyo-oka, T.; Kamishiro, T.; Hara, K.; Nakamura, N.; Kitahara, M.; Masaki, T. 1986: Suppression of myocardial protein degradation by the protease inhibitor bis[ethyl(2R,3R)-3-[(S)-methyl-1-[4-(2,3,4-tri-methoxy-phenyl-methyl) piperazine-1-ylcarbonyl]butyl-carbonyl]oxiran-2-carboxylat e]sulfate under hypoxia. Arzneimittel-Forschung 36(2): 190-193
Nishiyama, K.; Katori, M.; Ueno, A.; Ohno, T.; Saigenji, K. 1992: Suppression of myoelectrical activity of gastric smooth muscle by endogenous gastric prostaglandin E2. Digestive Diseases and Sciences 37(7): 1002-1008
Ghoneum, M.; Faisal, M.; Peters, G.; Ahmed, I.I.; Cooper, E.L. 1988: Suppression of natural cytotoxic cell activity by social aggressiveness in Tilapia. Developmental and Comparative Immunology 12(3): 595-602
Tanino, T.; Egawa, K. 1985: Suppression of natural cytotoxicity in tumor-bearing mice and inhibition of the suppression by D-mannose. Japanese Journal of Experimental Medicine 55(4): 155-160
Leu, R.W.; Norton, T.R.; Herriott, M.J.; Ringer, D.P.; Kearns, R.J. 1985: Suppression of natural killer and lymphocyte functions associated with carcinogen-induced premalignant hyperplastic nodules in rat liver. Cancer Research 45(7): 3282-3287